false Q3 --12-31 0001743745 P6M P6M P6M P6M P6M 0001743745 2024-01-01 2024-09-30 0001743745 2024-11-14 0001743745 2024-09-30 0001743745 2023-12-31 0001743745 us-gaap:普通A类股份成员 2024-09-30 0001743745 us-gaap:CommonClassAMember 2023-12-31 0001743745 us-gaap:普通B类股成员 2024-09-30 0001743745 美国通用会计准则:普通B类成员 2023-12-31 0001743745 2024-07-01 2024-09-30 0001743745 2023-07-01 2023-09-30 0001743745 2023-01-01 2023-09-30 0001743745 us-gaap:普通股成员 美国通用会计准则:普通A类成员 2023-12-31 0001743745 us-gaap:额外实收资本成员 2023-12-31 0001743745 us-gaap:留存收益成员 2023-12-31 0001743745 其他综合收益累计额成员 2023-12-31 0001743745 非控制权益成员 2023-12-31 0001743745 美国通用会计原则:普通股成员 美国通用会计原则:A类普通股成员 2024-03-31 0001743745 美国通用会计原则:资本溢价成员 2024-03-31 0001743745 美国通用会计原则:留存收益成员 2024-03-31 0001743745 美国通用会计原则:其他综合收益累计金额成员 2024-03-31 0001743745 美国通用会计原则:非控股权益成员 2024-03-31 0001743745 2024-03-31 0001743745 美国通用会计原则:普通股成员 美国通用会计原则:A类普通股成员 2024-06-30 0001743745 美元指数:其他资本公积金会员 2024-06-30 0001743745 美元指数:保留收益会员 2024-06-30 0001743745 美元指数:累积其他综合收益会员 2024-06-30 0001743745 美元指数:非控股权益会员 2024-06-30 0001743745 2024-06-30 0001743745 美元指数:普通股会员 美元指数:普通A类股会员 2022-12-31 0001743745 美元指数:普通股会员 美元指数:普通B类股会员 2022-12-31 0001743745 美元指数:其他股东资本成员 2022-12-31 0001743745 美元指数:留存收益成员 2022-12-31 0001743745 美元指数:其他综合收益累计额成员 2022-12-31 0001743745 美元指数:非控制权益成员 2022-12-31 0001743745 2022-12-31 0001743745 美元指数:普通股成员 美元指数:普通A类股成员 2023-03-31 0001743745 美元指数:普通股成员 美元指数:普通B类股成员 2023-03-31 0001743745 美国一般会计准则:股东追加投入资本成员 2023-03-31 0001743745 美国一般会计准则:留存收益成员 2023-03-31 0001743745 美国一般会计准则:其他综合收益累积成员 2023-03-31 0001743745 美国一般会计准则:非控制权益成员 2023-03-31 0001743745 2023-03-31 0001743745 美国一般会计准则:普通股成员 美国一般会计准则:普通A类股成员 2023-06-30 0001743745 美国一般会计准则:普通股成员 美国一般会计准则:普通B类股成员 2023-06-30 0001743745 美国通用会计准则:新增股本成员 2023-06-30 0001743745 美国通用会计准则:留存收益成员 2023-06-30 0001743745 美国通用会计准则:累计其他综合收益成员 2023-06-30 0001743745 美国通用会计准则:非控制权益成员 2023-06-30 0001743745 2023-06-30 0001743745 美国通用会计准则:普通股成员 美国通用会计准则:普通A类股成员 2024-01-01 2024-03-31 0001743745 美国通用会计准则:新增股本成员 2024-01-01 2024-03-31 0001743745 美国通用会计准则:留存收益成员 2024-01-01 2024-03-31 0001743745 US-GAAP:累计其他综合收益成员 2024-01-01 2024-03-31 0001743745 US-GAAP:非控股权益成员 2024-01-01 2024-03-31 0001743745 2024-01-01 2024-03-31 0001743745 US-GAAP:普通股成员 US-GAAP:普通A类股份成员 2024-04-01 2024-06-30 0001743745 US-GAAP:额外实收资本成员 2024-04-01 2024-06-30 0001743745 US-GAAP:留存收益成员 2024-04-01 2024-06-30 0001743745 US-GAAP:累计其他综合收益成员 2024-04-01 2024-06-30 0001743745 US-GAAP:非控股权益成员 2024-04-01 2024-06-30 0001743745 2024-04-01 2024-06-30 0001743745 US-GAAP:普通股股权成员 US-GAAP:A类普通股权成员 2024-07-01 2024-09-30 0001743745 US-GAAP:额外的资本溢价成员 2024-07-01 2024-09-30 0001743745 US-GAAP:留存收益成员 2024-07-01 2024-09-30 0001743745 US-GAAP:累计其他综合收益成员 2024-07-01 2024-09-30 0001743745 US-GAAP:非控制权益成员 2024-07-01 2024-09-30 0001743745 US-GAAP:普通股股权成员 US-GAAP:A类普通股权成员 2023-01-01 2023-03-31 0001743745 美国通用会计准则:普通股成员 美国通用会计准则:普通B类成员 2023-01-01 2023-03-31 0001743745 美国通用会计准则:附加支付资本成员 2023-01-01 2023-03-31 0001743745 美国通用会计准则:留存收益成员 2023-01-01 2023-03-31 0001743745 美国通用会计准则:累积其他综合收益成员 2023-01-01 2023-03-31 0001743745 美国通用会计准则:非控股权益成员 2023-01-01 2023-03-31 0001743745 2023-01-01 2023-03-31 0001743745 美国通用会计准则:普通股成员 美国通用会计准则:普通A类成员 2023-04-01 2023-06-30 0001743745 普通股票成员 普通B类成员 2023-04-01 2023-06-30 0001743745 额外实收资本成员 2023-04-01 2023-06-30 0001743745 留存收益成员 2023-04-01 2023-06-30 0001743745 累积其他综合收入成员 2023-04-01 2023-06-30 0001743745 非控股权益成员 2023-04-01 2023-06-30 0001743745 2023-04-01 2023-06-30 0001743745 普通股票成员 普通A类成员 2023-07-01 2023-09-30 0001743745 美元财务会计准则:普通股份类成员 美元财务会计准则:普通B类股份成员 2023-07-01 2023-09-30 0001743745 美元财务会计准则:额外实收资本成员 2023-07-01 2023-09-30 0001743745 美元财务会计准则:留存收益成员 2023-07-01 2023-09-30 0001743745 美元财务会计准则:累积其他综合收益成员 2023-07-01 2023-09-30 0001743745 美元财务会计准则:非控制权益成员 2023-07-01 2023-09-30 0001743745 美元财务会计准则:普通股份类成员 美元财务会计准则:普通A类股份成员 2024-09-30 0001743745 美国通用会计准则:额外资本缴付成员 2024-09-30 0001743745 美国通用会计准则:留存收益成员 2024-09-30 0001743745 美国通用会计准则:累积其他综合收益成员 2024-09-30 0001743745 美国通用会计准则:非控制权益成员 2024-09-30 0001743745 美国通用会计准则:普通股成员 美国通用会计准则:普通A类股成员 2023-09-30 0001743745 美国通用会计准则:普通股成员 美国通用会计准则:普通B类股成员 2023-09-30 0001743745 美国通用会计准则:股东附加已收资本 2023-09-30 0001743745 美国通用会计准则:留存收益 2023-09-30 0001743745 美国通用会计准则:累计其他综合收益 2023-09-30 0001743745 美国通用会计准则:非控制权益 2023-09-30 0001743745 2023-09-30 0001743745 美国通用会计准则:普通B类 2021-08-31 0001743745 美国通用会计准则:普通B类 2021-08-30 0001743745 普通C类会员 2021-08-31 0001743745 美国通用会计准则:普通A类 srt : 最小成员 2021-08-31 0001743745 美元指数:普通A类会员 srt : 最大成员 2021-08-31 0001743745 GNLN:Greenlane会员 美元指数:普通A类会员 2022-12-31 0001743745 GNLN:ATM方案会员 美元指数:普通A类会员 2021-08-31 2021-08-31 0001743745 美元指数:普通A类会员 GNLN: 自动取款机计划成员 2021-08-01 2022-12-31 0001743745 GNLN: 二零二三年七月发行成员 us-gaap: 普通A类成员 GNLN: 证券购买协议成员 2023-06-29 2023-06-29 0001743745 GNLN: 二零二三年七月发行成员 GNLN: 预资助认股权成员 srt: 最大成员 GNLN: 证券购买协议成员 2023-06-29 0001743745 GNLN:二零二三年七月发行会员 GNLN:证券购买协议会员 us-gaap:认股权证成员 SRT:最大会员 2023-06-29 0001743745 GNLN:二零二三年七月发行会员 GNLN:证券购买协议会员 2023-06-29 2023-06-29 0001743745 GNLN:证券购买协议会员 2024-08-12 2024-08-12 0001743745 GNLN:证券购买协议会员 2024-08-12 0001743745 GNLN:证券购买协议成员 GNLN:一份预先融资权证和两份普通权证成员 2024-08-12 0001743745 GNLN:贷款协议成员 2022-08-09 0001743745 GNLN:贷款协议成员 2023-02-09 2023-02-09 0001743745 GNLN:贷款协议成员 2023-02-09 0001743745 GNLN:贷款协议成员 2023-08-07 2023-08-07 0001743745 美元指数:投资者成员 2023-02-16 2023-02-16 0001743745 2023-07-31 0001743745 2023-08-31 0001743745 2023-10-31 0001743745 2023-11-30 0001743745 2023-09-22 2023-09-22 0001743745 us-gaap:担保债务成员 2023-09-22 0001743745 us-gaap:SecuredDebtMember 2023-09-22 2023-09-22 0001743745 us-gaap:SecuredDebtMember GNLN:贷款修改协议成员 2024-05-31 0001743745 us-gaap:SecuredDebtMember GNLN:贷款协议成员 2024-09-30 0001743745 GNLN:认购协议成员 2024-09-30 0001743745 GNLN:认购协议成员 2024-01-01 2024-09-30 0001743745 srt:最低要求成员 2024-09-30 0001743745 srt:最大会员 2024-09-30 0001743745 美国通用会计准则:客户集中风险会员 us-gaap:净销售收入成员 GNLN:一个客户会员 2024-07-01 2024-09-30 0001743745 us-gaap:客户集中风险成员 us-gaap:净销售收入会员 GNLN:两个客户会员 2024-07-01 2024-09-30 0001743745 us-gaap:客户集中风险成员 美元指数:净销售收入成员 GNLN:一个客户成员 2024-01-01 2024-09-30 0001743745 美元指数:客户集中风险成员 美元指数:净销售收入成员 GNLN:两个客户成员 2024-01-01 2024-09-30 0001743745 美元指数:客户集中风险成员 美元指数:净销售收入成员 GNLN:一个客户成员 2023-07-01 2023-09-30 0001743745 美国通用会计准则:客户集中风险成员 美国通用会计准则:销售净收入成员 GNLN:一个客户成员 2023-01-01 2023-09-30 0001743745 美国通用会计准则:客户集中风险成员 us-gaap:应收帐款会员 GNLN:一个客户成员 2024-01-01 2024-09-30 0001743745 美国通用会计准则:客户集中风险成员 美国通用会计准则:应收账款成员 GNLN: 客户一会员 2023-01-01 2023-12-31 0001743745 GNLN: Shavita BV会员 2024-05-31 0001743745 us-gaap:一级公允价值输入成员 2023-12-31 0001743745 美元指数:二级成员的公允价值输入 2023-12-31 0001743745 美国通用会计准则:FairValueInputsLevel3成员 2023-12-31 0001743745 GNLN: 备用考虑会员 2023-12-31 0001743745 GNLN: 备用考虑会员 2024-01-01 2024-09-30 0001743745 GNLN: 备用考虑会员 2024-09-30 0001743745 GNLN:有待考虑的附带条件成员 2022-12-31 0001743745 GNLN:有待考虑的附带条件成员 2023-01-01 2023-09-30 0001743745 GNLN:有待考虑的附带条件成员 2023-09-30 0001743745 GNLN:未来应收账款融资成员 2024-09-30 0001743745 GNLN:未来应收账款融资成员 2023-12-31 0001743745 GNLN:担保桥贷成员 2024-09-30 0001743745 GNLN:担保桥贷成员 2023-12-31 0001743745 GNLN:未来应收账款融资成员 srt:最低会员 2023-07-01 2023-07-31 0001743745 GNLN:未来应收款融资会员 srt:最低会员 2023-08-01 2023-08-31 0001743745 GNLN:未来应收款融资会员 srt:最低会员 2023-10-01 2023-10-31 0001743745 GNLN:未来应收款融资会员 srt:最低会员 2023-11-01 2023-11-30 0001743745 GNLN:未来应收款融资会员 srt : 最大成员 2023-07-01 2023-07-31 0001743745 GNLN: 未来应收账款融资会员 srt: 最大会员 2023-08-01 2023-08-31 0001743745 GNLN: 未来应收账款融资会员 srt: 最大会员 2023-10-01 2023-10-31 0001743745 GNLN: 未来应收账款融资会员 srt: 最大会员 2023-11-01 2023-11-30 0001743745 GNLN: 未来应收账款融资会员 2023-07-01 2023-07-31 0001743745 GNLN: 未来应收账款融资会员 2023-08-01 2023-08-31 0001743745 GNLN: 未来应收账款融资会员 2023-10-01 2023-10-31 0001743745 GNLN: 未来应收账款融资会员 2023-11-01 2023-11-30 0001743745 GNLN: 订阅协议会员 2024-06-07 2024-06-30 0001743745 GNLN: 订阅协议会员 2024-06-07 0001743745 GNLN: 担保桥梁贷款会员 2023-09-22 0001743745 GNLN: 担保桥梁贷款会员 2023-09-22 2023-09-22 0001743745 us-gaap:担保债务成员 GNLN:贷款修改协议成员 2024-05-01 2024-05-31 0001743745 us-gaap:应付贷款成员 2024-09-30 0001743745 2022-01-01 2022-12-31 0001743745 2023-02-16 0001743745 us-gaap:供应商集中风险成员 GNLN:采购基准成员 GNLN:四大供应商成员 2024-07-01 2024-09-30 0001743745 us-gaap:供应商集中风险成员 GNLN:采购基准成员 GNLN:四大供应商成员 2024-01-01 2024-09-30 0001743745 美元指数:供应商集中风险成员 GNLN:采购基准成员 GNLN:四大供应商成员 2023-07-01 2023-09-30 0001743745 美元指数:供应商集中风险成员 GNLN:采购基准成员 GNLN:四大供应商成员 2023-01-01 2023-09-30 0001743745 us-gaap:关联方成员 2022-01-01 2022-12-31 0001743745 美元指数:关联方成员 2024-09-30 0001743745 美国会计准则:关联方成员 2023-12-31 0001743745 GNLN:外币翻译成员 2023-12-31 0001743745 GNLN:衍生工具未实现收益或损失成员 2023-12-31 0001743745 GNLN:外币翻译成员 2024-01-01 2024-09-30 0001743745 GNLN:衍生工具未实现收益或损失成员 2024-01-01 2024-09-30 0001743745 其他综合收益累计额成员 2024-01-01 2024-09-30 0001743745 GNLN:外币翻译成员 2024-09-30 0001743745 GNLN:衍生工具未实现收益或损失成员 2024-09-30 0001743745 GNLN:外币翻译成员 2022-12-31 0001743745 GNLN:衍生工具未实现收益或损失成员 2022-12-31 0001743745 GNLN:外币翻译成员 2023-01-01 2023-09-30 0001743745 GNLN:衍生工具未实现收益或损失成员 2023-01-01 2023-09-30 0001743745 us-gaap:其他综合收益累积 2023-01-01 2023-09-30 0001743745 GNLN:外币翻译成员 2023-09-30 0001743745 GNLN:衍生工具未实现收益或损失成员 2023-09-30 0001743745 2023-06-05 2023-06-05 0001743745 GNLN:普通A和B类成员 2022-12-31 0001743745 GNLN: ATM计划会员 us-gaap:普通A类股份成员 2022-04-18 2022-04-18 0001743745 us-gaap:CommonClassAMember GNLN: 证券购买协议成员 2023-06-29 2023-06-29 0001743745 GNLN: 2023年7月发行会员 srt: 最大会员 GNLN: 证券购买协议成员 2023-06-29 0001743745 GNLN: 2023年7月发行会员 us-gaap:认股权证成员 2023-06-29 0001743745 GNLN:2023年7月份提供会员 美元指数:认股权证会员 2023-06-29 0001743745 GNLN:2023年7月份提供会员 GNLN:预先拟定认股权证会员 2023-06-29 0001743745 GNLN:2023年7月份提供会员 GNLN:预先拟定认股权证会员 2023-06-29 0001743745 GNLN:2023年7月份提供会员 GNLN:预先拨款认股权证成员 GNLN:谈判协议成员 2023-06-29 0001743745 GNLN:2023年7月份发行成员 GNLN:预先拨款认股权证成员 GNLN:谈判协议成员 2022-06-27 0001743745 GNLN:2023年7月份发行成员 GNLN:预先拨款认股权证成员 GNLN:谈判协议成员 2022-10-27 0001743745 GNLN:二零二三年七月的发行会员 GNLN:预先筹资认股权证会员 GNLN:协商协议会员 2023-06-29 2023-06-29 0001743745 us-gaap:CommonClassAMember GNLN:二零二四年八月的私募会员 GNLN:购买协议会员 2024-08-11 2024-08-12 0001743745 us-gaap:CommonClassAMember GNLN:二零二四年八月的私募会员 GNLN:二零二四年八月预先拟定认股权证会员 2024-08-11 2024-08-12 0001743745 us-gaap:普通A类会员 GNLN:二零二四年八月私人配售会员 GNLN:二零二四年八月标准认股权证会员 2024-08-11 2024-08-12 0001743745 GNLN:购买协议会员 GNLN:二零二四年八月私人配售会员 2024-08-11 2024-08-12 0001743745 GNLN:预先拟定认股权证会员 GNLN:二零二四年八月私人配售会员 2024-08-12 0001743745 us-gaap:普通股成员 GNLN:2024年8月私募会员 2024-08-12 0001743745 GNLN:2024年8月私募会员 2024-08-11 2024-08-12 0001743745 GNLN:2024年8月私募会员 2024-09-30 0001743745 GNLN:ATM方案会员 us-gaap:普通A类会员 2021-08-01 2024-09-30 0001743745 GNLN:股票合并会员 2024-07-01 2024-09-30 0001743745 GNLN:股票合并会员 2023-07-01 2023-09-30 0001743745 GNLN: 逆向股票拆分成员 2024-01-01 2024-09-30 0001743745 GNLN: 逆向股票拆分成员 2023-01-01 2023-09-30 0001743745 GNLN: 2019年股权激励计划成员 美国通用会计准则:A类普通股成员 2022-08-04 0001743745 GNLN: 2019年股权激励计划成员 美国通用会计准则:A类普通股成员 2023-06-01 2023-06-02 0001743745 美元指数:员工股票期权成员 美国通用会计准则:A类普通股成员 2024-07-01 2024-09-30 0001743745 员工股票期权成员 普通A类成员 2023-07-01 2023-09-30 0001743745 员工股票期权成员 普通A类成员 2024-01-01 2024-09-30 0001743745 员工股票期权成员 普通A类成员 2023-01-01 2023-09-30 0001743745 us-gaap:受限股票成员 普通A类成员 2024-07-01 2024-09-30 0001743745 美国通用会计准则:限制性股票成员 美国通用会计准则:普通A类成员 2023-07-01 2023-09-30 0001743745 美国通用会计准则:限制性股票成员 美国通用会计准则:普通A类成员 2024-01-01 2024-09-30 0001743745 美国通用会计准则:限制性股票成员 美国通用会计准则:普通A类成员 2023-01-01 2023-09-30 0001743745 GNLN:交换协议成员 us-gaap:后续事件成员 2024-10-29 0001743745 GNLN:交易协议成员 us-gaap:后续事件成员 GNLN:交易诱因认股权证成员 2024-10-29 0001743745 GNLN:交易协议成员 us-gaap:后续事件成员 GNLN:交易诱因认股权证成员 2024-10-29 2024-10-29 0001743745 GNLN:交易协议成员 GNLN:交易诱因认股权证成员 2024-08-13 0001743745 GNLN:交易协议成员 us-gaap:后续事项成员 2024-10-29 2024-10-29 0001743745 us-gaap:后续事项成员 GNLN:交易协议成员 GNLN:Cobra替代资本策略有限责任公司成员 2024-10-29 2024-10-29 0001743745 GNLN:注意修正成员 us-gaap:后续事项成员 GNLN:Cobra替代资本策略有限责任公司成员 2024-10-29 2024-10-29 0001743745 GNLN:注意修正成员 us-gaap:后续事项成员 GNLN:Cobra Alternative Capital Strategies LLC成员 2024-10-29 iso4217:美元指数 xbrli:股份 iso4217:美元指数 xbrli:份额 GNLN:整数 xbrli:纯形

 

 

 

美国

证券交易委员会

华盛顿,特区。20549

 

表格10-Q

 

(马克 一)

 

根据1934年证券交易法第13或15(b)条规定的季度报告

 

截至季度结束2024年9月30日, 2024

 

或者

根据1934年证券交易法第13或15(d)条款提交的过渡报告

 

过渡期从到

 

001-38875

(佣金 文档编号)

 

Greenlane Holdings,Inc。

(公司章程中指定的准确公司名称)

 

特拉华州   83-0806637

注册地或其他管辖区

公司所在地或组织机构

 

(美国国税局雇主号码)

(主要 执行人员之地址)

 

1095 Broken Sound Parkway, 套房100    
博卡 拉通, 佛罗里达州   33487
(主要 执行人员之地址)   (邮政 编 码)

 

(877) 292-7660

注册人的电话号码,包括区号

 

根据法案第12(b)节注册的证券:

 

每一类别的名称   交易符号   在每个交易所注册的名称
A类普通股,每股面值0.01美元   GNLN   纳斯达克 资本市场

 

请勾选是否注册人(1)在过去12个月内(或注册人被要求提交此类报告的较短期间)已提交所有根据1934年证券交易法第13条或15(d)条款需提交的报告,并且(2)在过去90天内是否受到此类提交要求的约束。是 ☐ No

 

请通过勾选来指示注册人是否在过去12个月(或注册人被要求提交此类文件的较短期间内)电子提交了根据规则405的S-t条例所需提交的每个互动数据文件。 是 ☐ No

 

请在选项前打勾,以指明注册人是大型加速申报人,加速清单申报人,非加速申报人,小型报告公司还是新兴成长公司。请参阅《交易所法》第120亿.2条中“大型加速申报人”,“加速清单申报人”,“小型报告公司”和“新兴成长公司”的定义。

 

大型加速文件提交人 加速文件提交人
非加速文件提交人 小型报告公司
    新兴成长公司

 

如果是新兴成长公司,请勾选,如果注册人已选择不使用根据交易所法案第13(a)条提供的任何新的或修改的财务会计准则的延长过渡期,请勾选。

 

请勾选适用的圆圈,表示注册登记者是否是空壳公司(根据交易所法案第12b-2条的定义)。是 ☐ 否

 

截至2024年11月14日,Greenlane Holdings, Inc.拥有 1,337,516 股A类普通股。

 

 

 

 
 

 

Greenlane Holdings,Inc。

表格 10-Q

截至2024年9月30日季度结束

 

目录

 

    页面
第一部分 财务信息  
项目 1. 基本报表(未经审计) 3
  汇编的综合资产负债表 3
  联合综合收益及损失简明合并报表 4
  股东权益的简化合并报表 5
  简明的综合现金流量表 6
  简明合并财务报表附注 8
项目 2. 分销计划 26
项目 3. 有关市场风险的定量和定性披露 37
项目 4. 控制和程序 37
     
第二部分 其他信息  
项目 1. 法律诉讼 38
Interest expense, net 风险因素 38
项目 2. 未注册的股权证券销售及所得用途,及发行人对股权证券的购买 40
项目5。 其他信息 40
项目 6. 展示资料 40
签名 41

 

2

 

 

股份注册声明中的规定 I

 

项目 1. 基本报表(未经审计)

 

greenlane控股有限公司。

汇编简明资产负债表

(以千为单位,除每股金额面值外)

 

   2024年9月 30日   2023年12月31日 
   (未经审计)     
资产          
流动资产          
现金  $2,309   $463 
应收账款,减除$的准备金2,251 和$2,209 分别于2024年9月30日和2023年12月31日   2,313    1,693 
存货净额   16,013    20,529 
供应商 存款   3,725    3,765 
其他 流动资产(注8)   2,279    3,319 
总计 当前资产   26,639    29,769 
           
不动产、机器及设备,净值   2,015    2,476 
营业租赁负债-流动部分   1,271    1,936 
其他资产   3,894    3,912 
总资产  $33,819   $38,093 
           
负债          
流动负债          
应付账款  $10,885   $12,103 
应计费用 和其他流动负债(注8)   2,521    3,056 
客户存款   1,255    2,775 
应付票据 减债务折扣   8,626    7,283 
经营租赁 当前部分   886    866 
融资租赁 当前部分       7 
流动负债合计   24,173    26,090 
           
经营租赁 减去当前部分   326    1,010 
其他负债       1 
总长期负债   326    1,011 
总负债   24,499    27,101 
承诺 和或有事项(注7)   -     -  
           
股东权益          
优先股,$0.0001 面值, 10,000 授权股份, 已发行并流通        
A类普通股,$0.0005股,截至2024年4月30日和2024年1月31日,授权股票0.0005股;0.01 每股面值, 600,000 授权股份数, 972 股票于2024年9月30日发行和流通; 600,000 授权股票数, 339 股票于2023年12月31日发行和流通*   8    3 
B类普通股,$0.000030.0001 每股面值, 30,000 授权股票数,并 0 股票于2024年9月30日和2023年12月31日的已发行和流通*        
           
额外 资本*   275,365    268,165 
累计亏损   (266,152)   (257,289)
累计 其他综合收益   248    245 
总 归属greenlane控股公司的股东权益   9,469    11,124 
非控股 权益   (149)   (132)
总股东权益   9,320    10,992 
负债和股东权益总计  $33,819   $38,093 

 

* 在 实施反向拆股之后 - 见第9条 - 股票持有者权益。

 

附注是这些未经审计的简明综合财务报表的组成部分。

 

3

 

 

greenlane控股有限公司。

压缩合并损益表和综合损失表

(未经审计)

(单位:千美元,每股金额除外)

 

   2024   2023   2024   2023 
   截至9月30日的三个月   截至9月30日的九个月 
   2024   2023   2024   2023 
                 
净销售额  $4,038   $11,800   $11,616   $55,384 
销售成本   1,011    8,671    6,066    42,162 
毛利润   3,027    3,129    5,550    13,222 
营业费用:                    
薪资、福利和工资税   1,609    4,059    6,066    14,586 
一般及行政费用   1,771    5,433    6,864    20,209 
折旧和摊销   185    524    635    1,492 
总营业费用   3,565    10,016    13,565    36,287 
经营亏损   (538)   (6,887)   (8,015)   (23,065)
                     
其他收益(费用),净:                    
利息费用   (3,219)   (3,415)   (4,030)   (5,148)
可换履行条件公允价值变动           1,000     
偿还债务所获利润           2,166     
其他收入(费用),净额       204    (3)   338 
其他总收益(费用),净额   (3,219)   (3,211)   (867)   (4,810)
税前亏损   (3,757)   (10,098)   (8,882)   (27,875)
所得税的准备金(福利)               (6)
净亏损   (3,757)   (10,098)   (8,882)   (27,869)
净利润归非控股权益人的净收益(损失)       19    (17)   (27)
归属于Greenlane Holdings,Inc.的净亏损  $(3,757)  $(10,117)  $(8,865)  $(27,842)
每股净损失归属于A类普通股 - 基本和摊薄(注9)*  $(2.28)  $(1.91)  $(12.20)  $(9.67)
A类普通股的加权平均在外流通股数 - 基本和摊薄(注9)*   1,647    5,513    727    2,918 
其他全面收益(损失):                    
外币转换调整   

4

    24    3    181 
全面损失   (3,753)   (10,122)   (8,879)   (27,688)
扣除归属于非控制权益的综合损失           (17)   (8)
归属于greenlane控股公司的综合亏损。  $(3,753)  $(10,122)  $(8,862)  $(27,680)

 

* 在 实施反向拆股之后 - 见第9条 - 股票持有者权益。

 

附注是这些未经审计的简明综合财务报表的组成部分。

 

4

 

 

greenlane控股有限公司。

简明的股东权益合并财务报表

(未经审计)

(以千为单位)

 

   股份*   金额*   资本*   赤字   收入(损失)   利息   股本 
   A类普通股   股本所对应的账面超额支付   累积   累计其他综合   非控制权   股东总数 
   股份*   金额*   Capital*   赤字   收入(亏损)   利息   股本 
2023年12月31日余额   339   $3   $268,165   $(257,289)  $245   $(132)  $10,992 
净亏损               (4,491)           (4,491)
基于股权的补偿   17        86                86 
发行A类股份 -(注释9)   38    1    (1)                
其他综合收益                   2        2 
2024年3月31日余额   394   $4   $268,250   $(261,780)  $247   $(132)  $6,589 
净损失               (615)       (17)   (632)
发行A类股份-(附注9)   135    1    (1)                
其他综合收益                   (3)       (3)
2024年6月30日结余   529   $5   $268,249   $(262,395)  $244   $(149)  $5,954 
净损失               (3,757)           (3,757)
发行A类股份和认股权证-(附注9)   443    3    7,116                

7,119

 
其他综合收益                   4        4 
2024年9月30日的余额   972   $8   $275,365   $(266,152)  $248   $(149)  $9,320 

 

* 在 实施反向拆股之后 - 见第9条 - 股票持有者权益。

 

   股份*   金额*   股份*   金额*   资本*   赤字   收入(损失)   利息   股本 
   A类
普通股
   B类普通股   附加
实收资本
   累积   累计
其他综合收益
   非控制   股东总数 
   股份*   金额*   股份*   金额*   Capital*   赤字   收入(损失)   利息   股本 
2022年12月31日余额   145   $1       $   $264,031   $(225,114)  $55   $18   $38,991 
净亏损                       (8,693)       (54)   (8,747)
基于股权的补偿                   110                110 
发行A类股股份 - 修订Eyce APA(附注3)                   95                95 
其他综合收益                           178        178 
2023年3月31日余额   145    1            264,236    (233,807)   233    (36)   30,627 
                                              
净亏损                       (9,032)       8    (9,024)
基于股权的补偿没收,净额                   (11)               (11)
A类股份发行-修订Eyce APA(注3)                   65                65 
其他全面收入(损失)                           27        27 
2023年6月30日余额   145   $1       $   $264,290   $(242,839)  $260   $(28)  $21,684 
净亏损                       (10,117)       19    (10,098)
基于股权的补偿                   (70)               (70)
发行A类股份-修订版Eyce APA(注3)                       65                     
发行A类股份(注9)   168    2              3,850                   3,852 
其他全面收入(损失)                           (22)       (22)
2023年9月30日余额   313   $3       $   $268,105   $(252,956)  $238   $(9)  $15,411 

 

* 在 实施反向拆股之后 - 见第9条 - 股票持有者权益。

 

附注是这些未经审计的简明综合财务报表的组成部分。

 

5

 

 

greenlane控股有限公司。

简明综合现金流量表

(未经审计)

(以千为单位)

 

   2024   2023 
   截至九月三十日止九个月。 
   2024   2023 
         
经营活动现金流量:          
净亏损(包括归属于非控股权益的金额)  $(8,882)  $(27,869)
调整为净损失到经营活动现金流量净使用:          
折旧和摊销   635    1,492 
基于股权的薪酬费用   86    255 
坏账准备变动   41    (154)
可换履行条件公允价值变动   (1,000)   103 
债务折价和递延融资费用摊销   3,373    2,711 
偿还债务所获利润   (2,166)    
其他       (17)
运营资产和负债变动,除收购影响外净值:          
应收账款的增加(减少)   (660)   4,697 
    预付款项及其他流动资产减少   4,516    18,005 
供应商存款减少   40    2,945 
其他流动资产减少   1,058    3,968 
应付账款的增加(减少)   (1,221)   (3,121)
应计费用及其他负债增加(减少)   468    (250)
客户存款减少   (1,520)   (1,573)
经营活动中提供的净现金流量(流出)   (5,232)   1,192 
投资活动现金流量:          
           
不动产和设备的购买净额   (173)   (633)
出售股权投资的收益       53 
投资活动所使用的净现金   (173)   (580)
筹集资金的现金流量:          
Eyce和DaVinci的承诺票据支付       (2,539)
Eyce LLC和DaVinci收购的购买对价        (300)
资产基础贷款的偿还       (15,000)
资产基础贷款的修改成本       (751)
发行A类普通股和warrants的收益,扣除成本   

5,640

    3,852 
行使股票期权的收益,扣除成本   1,477     
担保过桥贷款的收益,扣除成本   

    2,090 
还款应付票据   

(2,100

)   

 
票据应收款的收入   2,950     
未来应收款融资的收益   225    3,000 
针对未来应收账款的贷款还款   (939)   (851)
其他   (5)   (29)
筹集资金的净现金流量   7,248    (10,528)
汇率变动对现金的影响   3    183 
现金净减少额   1,846    (9,733)
期初的现金和受限现金   463    12,176 
期末的现金和受限现金  $2,309   $2,443 

 

附注是这些未经审计的简明综合财务报表的组成部分。

 

6

 

 

greenlane控股有限公司。

精简综合现金流量表(续)

(未经审计)

(以千为单位)

 

现金与受限现金的调节 以合并资产负债表为准

 

   截至九月三十日止九个月。 
   2024   2023 
期初          
现金  $463   $6,458 
受限现金       5,718 
期初现金及受限现金总额  $463   $12,176 
           
期末          
现金  $2,309   $2,443 
受限现金        
期末总现金和限制现金  $2,309   $2,443 
           
现金流补充资料披露          
支付的利息现金  $778   $4,495 
用于计量租赁负债的现金支付  $   $1,353 
           
非现金融资活动:          
非现金购买固定资产和设备  $   $133 
与协同资产购买协议相关的债务解除  $2,658   $ 
从或有对价转入应付票据  $   $1,150 
从应计费用转至应付票据  $   $437 

 

附注是这些未经审计的简明综合财务报表的组成部分。

 

7

 

 

greenlane控股有限公司。

简明合并财务报表附注

(未经审计)

 

注释1。业务运营与组织

 

组织

 

greenlane 控股公司(“greenlane”,以及与运营公司(如下所定义)及其合并子公司统称为“公司”、“我们”、“我们”和“我们的”)于2018年5月2日在特拉华州成立。我们是一家控股公司,成立的目的是完成股份的承销首次公开募股(“IPO”),即我们的A类普通股,每股面值$0.01(“A类普通股”),以便开展greenlane Holdings, LLC(“运营公司”的业务)。运营公司于2015年9月1日在特拉华州成立,总部位于佛罗里达州博卡拉顿。除非上下文另有要求,提及“公司”时均指我们及我们的合并子公司,包括运营公司。

 

我们在美国、加拿大、欧洲和拉丁美洲销售优质的大麻配件、防儿童打开包装、专业的蒸发解决方案和生活用品,为广泛的多样化客户群提供服务,拥有数千个零售店、持牌大麻零售店、烟店、跨州经营者(“MSOs”)、专业零售商和零售消费者。

 

我们 一直在开发自己的专有品牌组合(“greenlane品牌”),我们相信这些品牌随着时间的推移, 能够提供更高的利润并为我们的客户和股东创造长期价值。我们全资拥有的greenlane品牌包括Groove – 我们的更实惠产品系列,以及Higher Standards – 我们的高端烟草商店和辅助产品品牌,还有我们的获奖 网站和品牌Vapor.com。我们还有针对高端Marley Natural品牌产品的类别独家许可,以及k.Haring品牌产品的许可。

 

我们 是运营公司的唯一管理者,我们的主要资产是运营公司的普通单位(“普通单位”)。 作为运营公司的唯一管理者,我们负责运营和控制运营公司的所有业务和事务,我们通过运营公司及其子公司进行业务。我们有董事会和高管,但没有员工。所有的资产都由运营公司的全资子公司持有,所有员工都在这些全资子公司工作。

 

我们 拥有万亿.e运营公司的唯一投票权益,并且控制其管理,我们有义务承担运营公司的损失,并从中获得收益,损失可能是相当显著的。我们确定运营公司是一个变量 利益实体(“VIE”),我们是运营公司的主要受益者。因此,按照VIE会计模型,从2019年6月30日结束的财政季度开始,我们将运营公司合并到我们的综合基本报表中,并在我们的综合基本报表中报告与运营公司的成员(除了我们持有的普通单位)持有的普通单位相关的非控制性权益。

 

在2021年8月31日,我们完成了与KushCo Holdings, Inc.(“KushCo”)的合并,并已从该日期起将KushCo的经营结果纳入我们的合并经营报表和综合损失中。为了与KushCo的合并相关,greenlane的公司章程被修订和重述(“A&R章程”),以(i)增加greenlane B类普通股的授权股份数量,$0.0001 每股面值为的普通股(“B类普通股”),从 10 百万股。 30 百万股,以使每一股已发行的C类普通股,$0.0001每股面值为的普通股(“C类普通股”)转换为三分之一的B类普通股,(ii)将A类普通股的授权股份数量从 125 百万股增加至 600 百万股,以及(iii)删除对C类普通股的引用。根据与KushCo于2021年3月31日签订的合并协议的条款(“合并协议”),在业务合并完成之前,C类普通股的持有者在合并结束前立即收到每持有一股C类普通股可获得三分之一的B类普通股。

 

我们的公司结构通常被称为“Up-C”结构。 Up-C结构允许运营公司继续实现持有被视为合作伙伴关系或“透支”的实体利益所关联的税收优惠。其中之一的好处是,分配给其成员的运营公司未来应税收入将根据流程进行征税,因此不会在运营公司实体级别上受到公司税的影响。此外,由于成员可以按一比一的比例换回他们的普通单位以换取A级普通股或根据我们的选择换取现金,Up-C结构还为成员提供了非公开交易有限责任公司的持有人通常不提供的潜在流动性。

 

8

 

 

关于首次公开发行(IPO),我们与经营公司及经营公司成员签订了税务索取协议(“TRA”)和注册权协议(“注册权协议”)。TRA规定我们向经营公司成员支付税务收益的%i(如果有的话),这是由于上述机制下普通单位的赎回导致我们对经营公司资产的税基调高,以及根据TRA支付的其他某些税务收益。根据注册权协议,我们同意登记发行A类普通股的股份,这些股份可在经营公司成员根据普通单位的赎回或交换而应享有。 85.0我们与经营公司及经营公司成员签订了税务索取协议(TRA)和注册权协议。TRA规定,我们将根据协议支付的税收收益的%i(如果有的话),这是由于我们在经营公司资产中的股份的税基调高(由上述普通单位赎回机制引发),以及某些其他可归因于TRA支付的税收收益。根据注册权协议,我们同意注册A类普通股的股份,这些股份将在经营公司成员根据普通单位的赎回或交易而发行。

 

根据《经营公司的A&R宪章》和《经营公司修正与重订的第四份营运协议》(“经营协议”)的要求,(a)我们必须始终保持我们拥有的每股普通单位与我们发行的A类普通股之间的比例为一比一(适用于某些例外情况),以及(b)经营公司必须始终保持(i)我们发行的A类普通股与我们拥有的普通单位数量之间的一比一比例,以及(ii)经营公司非创始成员拥有的B类普通股与非创始成员拥有的普通单位数量之间的一比一比例。

 

截至2022年12月31日,所有运营公司的普通股和B类普通股均已交换为A类普通股,我们拥有 100绿巷所有板块的选举和经济权益的%都是通过持有A类普通股实现的。请参阅“注9 - 股东权益。”

 

拆股并股

 

在2023年6月2日,我们向特拉华州国务卿("SSSD")提交了《修正证书》, 该证书实施了一次十股合一的反向拆股("2023年反向拆股",与2022年反向拆股共同称为"拆股并股"), 自2023年6月5日下午5:01(东部时间)生效。因此,所有已发行的普通股每十股转换为一股普通股。 我们以现金支付碎股的补偿,因此, 在2023年反向拆股中没有发行任何碎股。

 

2024年7月23日,董事会批准以1比11的比例进行反向拆股,并已向特拉华州国务卿提交修正案,该修正案于2024年8月5日东部时间凌晨12:01生效,在纳斯达克开盘之前。

 

拆股并股并未改变普通股的面值或普通股的授权股数。所有未行使期权、受限股票奖励、权证和其他证券以购买或以其他方式获取我们普通股的持有人,均因拆股并股而进行了调整,根据每种证券的条款要求。根据修改和重订的2019年股权激励计划,可授予的股份数量也已适当调整。有关更多信息,请参阅“注10-薪酬计划”.

 

这些合并财务报表和相关附注中的所有股份和每股股份金额都已经为所有报告期进行了反向拆股并股的调整,其中包括将普通股的面额减少的金额重新分类为其他股本。

 

流动性和继续经营

 

根据ASC 205-40《基本报表呈现——行将发生事项》(“ASC 205-40”),管理层必须评估是否有条件和事件,在总体上考虑,对公司在这些简明综合财务报表发放之后的一年内能否作为一个持续经营点提出重大疑义。根据ASC 205-40的规定,管理层的分析只可以包括对管理层计划潜在缓解影响的部分,前提是(a)有潜力使管理层计划在及时的基础上得到有效实施,且(b)当计划得到实施时,将减轻提出对公司持续经营提出重大疑义的相关条件或事件。

 

我们对流动性和资本的主要需求是运营资金、最近收购相关的债务偿还以及公司的一般需求。我们的主要流动性来源是手头现金和来自经营活动产生的现金流,以及其他股权发行的收入。

 

我们 相信我们的现金和我们从运营中产生的现金流将不足以资助我们的流动资金 和资本支出需求,以及与我们现有运营相关的债务偿还和其他流动性需求, 在接下来的12个月内。根据我们截至2024年9月30日的现金和流动资金,我们可能没有足够的现金来资助计划的 运营进入2024年第四季度。这从我们持续努力筹集资本和利用外部资金 来满足我们的资本需求中显而易见。

 

9

 

 

自动取款机 计划和架子注册声明

 

以前我们使用Form S-3表格上的架构注册声明(“架构注册声明”)不时进行证券发行,以满足我们的流动性需求。为了满足我们的流动性需求,我们曾经使用注册声明来进行有价证券发行。2021年8月,我们提交了招股说明书,并设立了“按市场价格”股权发行计划(“ATM计划”),该计划允许不时出售我们的A类普通股,总发行价高达$50 百万。

 

自2021年8月启动ATm计划至2022年12月31日,我们出售了我
们的A类普通股,获得了约$的总收益。12.7 百万美元,并向销售代理支付约百万美元的费用。0.4 由于某些季度报告和年度报告的提交时间不当,我们无法根据ATm计划发行额外的A类普通股,或者以其他方式使用备选登记声明,这将限制我们在资本市场的流动性选择。

 

普通股票和认股权发行。

 

在2023年6月29日,我们与某些投资者签署了证券购买协议,约定我们将发行并卖出合计 560,476 股的A类普通股、预先资金的认股权证,最多可购买 3,487,143 股A类普通股(“2023年7月预先资金认股权证”)以及认股权证,最多可购买 8,095,238 股A类普通股(“2023年7月标准认股权证”)。2023年7月单位是依据注册声明S-1表格(“2023年7月发行”)进行的。2023年7月发行产生了约4.3 百万美元的毛收入,以及公司获得的约3.8 百万美元的净收入,并于2023年7月3日完成。有关更多信息,请参见“注释9 - 股东权益”。

 

2024年8月12日,公司与一家机构投资者签订了一份证券购买协议,总计筹集的现金净额为$6.5 百万。与私募相关,公司将发行总计 2,363,637 单位和预定单位。预定单位将以与单位相同的购买价格出售,减去0.00001预定单位权证行权价格为$。每个单位和预定单位将包括一份普通股份(或一份预付权证)和两份普通权证,每份权证行权价格为$2.50普通股股东有一票权。普通权证将可在普通权证中描述的初始行权日期行使,并将在该日期起5.0年后到期。

 

基于资产的贷款

 

2022年8月9日,我们签订了截至2022年8月8日的基于资产的贷款协议(“贷款协议”),为公司提供了最多$的一笔年限贷款。15.0 2023年2月9日,我们签署了贷款协议的第二号修正案,在其中我们同意在贷款协议规定的条件下自愿预付约$的款项(包括提前终止费用和支出),并且贷款协议的放款人同意释放根据贷款协议条款在受限账户中持有的$资金。6.6 2022年8月9日,我们签订了截至2022年8月8日的基于资产的贷款协议(“贷款协议”),为公司提供了最多$的一笔年限贷款。5.7 2022年8月9日,我们签订了截至2022年8月8日的基于资产的贷款协议(“贷款协议”),为公司提供了最多$的一笔年限贷款。

 

在2023年8月7日,我们偿还了约$4.3 百万的总本金(“贷款偿还”),根据贷款协议的条款,尚未偿还。 由于贷款偿还,公司依据贷款协议的条款,被解除其在贷款协议下的义务。 有关更多信息,请参见“注6 - 长期债务”。

 

10

 

 

ERC 销售

 

2023年2月16日,我们全资拥有的子公司Warehouse Goods LLC和Kim International LLC与第三方机构投资者达成协议,根据该协议,投资者以现金约xx百万美元购买了我们通过雇员留任信用计划申报所享有的针对特定时期由美国国内税务局支付的权益的经济参与权利,该权益享有折扣。4.9 现已成功翻译。

 

未来 应收账款融资

 

在2023年7月、8月、10月和11月,公司根据与两家私人贷方达成的未来应收款融资的条款,总共收到约$3.9 百万现金。 截至2024年9月30日,这种融资仍有$4.6 百万未偿还。有关更多信息,请参见“注释6 - 长期债务”。

 

担保 桥贷

 

2023年9月22日,公司根据《贷款和安全协议》(以下简称“2023年9月贷款协议”)与Synergy Imports,LLC(以下简称“担保桥梁贷款贷款人”)达成了一项有担保的贷款。

 

根据2023年9月贷款协议,担保桥梁贷款放款人同意向公司提供 -个月桥梁贷款 新资金$2.2 百万美元。此外,担保桥梁贷款放款人同意推迟支付已到期的$2,028,604 公司根据现有付款义务欠付的款项,并有可能推迟最多额外的$2,655,778 ,这可能根据2023年9月贷款协议的约定在协议期内到期。

 

在某些例外情况下,公司同意以所有资产(不包括存入资金账户和应收账款)作为抵押。此外,公司同意转让一项美国专利、两项相关的外国专利以及一项相关商标,以换取在2023年9月贷款协议中与吸烟产品及配件相关的这些资产的独家许可。

 

2024年5月,公司修改了与协同能源的债务协议,以减少到期的本金余额$2.7百万美元,使其从$5.1 百万美元 作为贷款修改协议的一部分,同时与资产购买协议同时进行。协同能源从公司收购了某些资产, 以换取总体本金的减少。截至2024年9月30日,该融资中仍有$2.7 百万美元未偿还。 更多信息请参阅“注释6-长期负债”.

 

注意 应付款

 

开启 2024年6月7日,公司与Cobra Alternative Capital Strategies, LLC签订了认购协议。截至9月30日 2024 年,该公司已获得贷款 $3.1 百万,净现金收益为美元2.6 百万。该照会印发时附带了 20% 原发行折扣,全额到期 十二月 2024 年 7 月 7 日。有关更多信息,请参阅 “附注6——长期债务”。在截至2024年9月30日的三个月中, 公司偿还了美元2.1 百万美元,剩余的未清余额约为美元1.0 百万。公司已选择使用ASC 825 “金融工具” 下的公允价值期权来衡量这些票据。 鉴于票据的短期期限,截至2024年9月30日的票据账面价值接近公允价值,因此 业务报表中没有记录公允价值调整。

 

管理 倡议

 

由于无法公平地进入资本市场,并且库存缺货和高速库存短缺,我们已经完成了几项举措,优化了我们的营运资本需求。2022年第四季度,我们推出了Groove,一个新颖的greenlane品牌产品线,同时我们还对第三方品牌产品进行了合理化和改进,在增加我们的产品种类的同时,减少了库存资金成本和营运资本需求。

 

2023年4月,我们进入了战略伙伴关系。 首先,我们与A&A Global Imports(也称为MarijuanaPackaging.com)达成了战略合作关系(“MJ包装合作关系”),后者是大麻行业包装解决方案的主要供应商。于2024年8月8日,公司终止了与MJ包装的战略合作关系,并恢复了作为大麻行业包装解决方案的直接提供商的业务。然而,MJ包装仍然是公司的分销客户。

 

其次,我们与我们现有烟雾供应商的一个附属公司(“烟雾合作伙伴”)建立了战略合作伙伴关系, 为某些关键客户提供蒸发器商品和服务(“烟雾合作关系”)。作为烟雾合作关系的一部分, 我们将向我们的烟雾合作伙伴介绍某些关键客户,协助推广和出售某些蒸发器商品和服务, 并帮助协调物流、存储和配送这些蒸发器产品。如果我们的烟雾合作伙伴与关键客户之间建立直接关系, 客户将直接从我们的烟雾合作伙伴那里购买我们目前出售给他们的蒸发器商品和服务, 我们将不再需要代表这些关键客户购买这些烟雾库存。作为交换,我们将从我们的战略合作伙伴那里获得季度和年度佣金。 虽然战略合作伙伴关系可能会导致这些烟雾产品的营业收入下降, 但此合作关系结合我们的其他重组措施应该能够帮助我们降低整体成本结构,提高我们的利润,从而改善我们的资产负债表。

 

我们 已经成功地重新谈判了许多供应商和合作伙伴的合作条款,并继续改善与供应商和合作伙伴的营运资金安排。 我们在整合和简化我们的办公室、仓库和配送运营布局方面取得了进展。 我们大幅减少了员工数量,以降低成本并与我们的营业收入预测保持一致。

 

公司在截至2024年9月30日和2023年9月30日的九个月里已经产生了净亏损$8.9 分别为截至2024年和2023年九月30日的九个月,分别为$27.8 百万。对于截至2024年9月30日和2023年9月30日的九个月,经营活动产生的现金(使用)为$(5.2) 百万和$1.2 百万,分别如此。近期的宏观经济环境导致的需求低于公司业务计划中预测的水平,这导致在持续经营评估中所包括的12个月的营业收入和现金流的降低。

 

11

 

 

由于我们的亏损以及我们预期的现金需求,再加上我们当前的流动性水平,关于公司能否作为持续经营实体的疑虑是存在的。公司作为持续经营实体的能力取决于成功执行管理层未来十二个月计划,以改善公司的流动性和盈利能力,其中包括但不限于:

 

  进一步通过采取额外的重组措施来降低运营成本,以使成本与营业收入相匹配,实现盈利。
     
  通过引入新产品、获取新客户和增强我们的销售队伍来增加营业收入。
     
  执行与利润率和运营现金流有利的战略伙伴关系。
     
  通过发行债务或股票证券寻求额外的资本。

 

未经审计的简明综合财务报表不包括可能由于这一持续经营不确定性结果而引发的任何调整。有关我们举措的更完整描述,请参阅管理层讨论与分析。

 

备注2。重要会计政策摘要

 

表述基础

 

Our unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2023. The condensed consolidated results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024, or any other future annual or interim period. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments necessary for a fair statement of the Company’s financial position and operating results. Certain reclassifications have been made to prior year amounts or balances to conform to the presentation adopted in the current year.

 

Principles of Consolidation

 

Our condensed consolidated financial statements include our accounts, the accounts of the Operating Company, and the accounts of the Operating Company’s consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

12

 

 

Use of Estimates

 

Conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts in our consolidated financial statements and accompanying notes. These estimates form the basis for judgments we make about the carrying values of our assets and liabilities, which are not readily apparent from other sources. We base our estimates and judgments on historical information and on various other assumptions that we believe are reasonable under the circumstances. U.S. GAAP requires us to make estimates and judgments in several areas. Such areas include, but are not limited to the following: the collectability of accounts receivable; the allowance for slow-moving or obsolete inventory; the realizability of deferred tax assets; the fair value of contingent consideration arrangements; the useful lives property and equipment; the calculation of our VAT taxes receivable and VAT taxes, fines, and penalties payable; our loss contingencies, including our TRA liability; and the valuation and assumptions underlying equity-based compensation. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. The actual results could differ materially from those estimates.

 

Segment Reporting

 

We manage our global business operations through our operating and reportable business segments. As of September 30, 2024, we determined that we have one remaining and reportable operating business segment. Our reportable segment has been identified based on how our chief operating decision maker (“CODM”), which is a committee comprised of our Chief Executive Officer (“CEO”) and our Chief Financial and Legal Officer (“CFO”), manages our business, makes resource allocation and operating decisions, and evaluates operating performance.

 

Revenue Recognition

 

Revenue is recognized when customers obtain control of goods and services promised by us. Revenue is measured based on the amount of consideration that we expect to receive in exchange for those goods or services, reduced by promotional discounts and estimates for return allowances and refunds. Taxes collected from customers for remittance to governmental authorities are excluded from net sales.

 

We generate revenue primarily from the sale of finished products to customers, whereby each product unit represents a single performance obligation. We recognize revenue from product sales when the customer has obtained control of the products, which is either at point of sale or delivery to the customer, depending upon the specific terms and conditions of the arrangement, or at the point of sale for our retail store sales. We provide no warranty on products sold. Product warranty is provided by the manufacturers. For certain product offerings such as child-resistant packaging, closed-system vaporization solutions and custom-branded retail products, we may receive a deposit from the customer (generally 25% - 50% of the total order cost, but the amount can vary by customer contract) when an order is placed by a customer. We typically complete these orders within one to six months from the date of order, depending on the complexity of the customization and the size of the order, but the completion timeline can vary by product type and terms of sales with each customer. See “Note 8—Supplemental Financial Statement Information” for a summary of changes to our customer deposits liability balance during the nine months ended September 30, 2024 and the year ended December 31, 2023.

 

We estimate product returns based on historical experience and record them as a refund liability that reduces the net sales for the period. We analyze actual historical returns, current economic trends and changes in order volume when evaluating the adequacy of our sales returns allowance in any reporting period. Our liability for returns, which is included within “Accrued expenses and other current liabilities” in our consolidated balance sheet, was approximately $0.1 million December 31, 2023. There were no liabilities related to refunds as of September 30, 2024.

 

We elected to account for shipping and handling expenses that occur after the customer has obtained control of products as a fulfillment activity in cost of sales. Shipping and handling fees charged to customers are included in net sales upon completion of our performance obligations. We apply the practical expedient provided for by the applicable revenue recognition guidance by not adjusting the transaction price for significant financing components for periods less than one year. We also apply the practical expedient provided by the applicable revenue recognition guidance based upon which we generally expense sales commissions when incurred because the amortization period is one year or less. Sales commissions are recorded within “Salaries, benefits and payroll tax expenses” in the consolidated statements of operations and comprehensive loss.

 

The Company transitioned to a commission revenue model for the majority of the sales for the Industrial segment. The company operates as a sales agent servicing vape customers and receives a commission for these services. The company was previously working directly with these customers and recognizing gross revenue versus straight commission revenue. The Company recognizes this fee on a periodic basis when the products have been shipped for the end consumer. In working with their partner, the Company is not responsible for fulfilling a promise to provide the specified goods, does not establish the pricing with its partners customers, and does not have control over the goods that will be shipped. As such, the Company is an agent and recognizes its revenue on a net basis for its service. The partner company pays Greenlane a negotiated percentage-based fee on a quarterly basis.

 

Two customers represented approximately 36% and 27%, respectively, of net sales for the three months ended September 30, 2024. Two customers represented approximately 16% and 16%, respectively, of net sales for the nine months ended September 30, 2024. For the three and nine months ended September 30, 2023, one customer represented approximately 13% and 28% of net sales. As of September 30, 2024 and December 31, 2023, the Company has a concentration of credit risk with its accounts receivable balance as one customer represented approximately 15% and 31%, respectively, of accounts receivable.

 

13

 

 

Value Added Taxes

 

During the third quarter of 2020, as part of a global tax strategy review, we determined that our European subsidiaries based in the Netherlands, which we acquired on September 30, 2019, had historically collected and remitted value added tax (“VAT”) payments, which related to direct-to-consumer sales to other European Union (“EU”) member states, directly to the Dutch tax authorities. In connection with our subsidiaries’ payment of VAT to Dutch tax authorities rather than other EU member states, we may become subject to civil or criminal enforcement actions in certain EU jurisdictions, which could result in penalties.

 

We performed an analysis of the VAT overpayments to the Dutch tax authorities, which we expected to be refunded to us, and VAT payable to other EU member states, including potential fines and penalties. Based on this analysis, we recorded VAT payable of approximately $0.6 and $0.4 million, respectively, relating to this matter within “Accrued expenses and other current liabilities” in our condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023.

 

Pursuant to the purchase and sale agreement by which we acquired our European subsidiaries, the sellers are required to indemnify us against certain specified matters and losses, including any and all liabilities, claims, penalties and costs incurred or sustained by us in connection with non-compliance with tax laws in relation to activities of the sellers. The indemnity (or indemnification receivable) is limited to an amount equal to the purchase price under the purchase and sale agreement.

 

As noted above, we have voluntarily disclosed VAT owed to several relevant tax authorities in the EU member states and believe in doing so we will reduce our liability for penalties and interest. Nonetheless, we may incur expenses in future periods related to such matters, including litigation costs and other expenses to defend our position. The outcome of such matters is inherently unpredictable and subject to significant uncertainties. Refer to “Note 7—Commitments and Contingencies” for additional discussion regarding our contingencies.

 

Recently Issued Accounting Guidance Not Yet Adopted

 

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security’s unit of account. This standard is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of adopting the standard.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this update require public companies to disclose on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker (CODM) and require that a public entity disclose, on an annual and interim basis, an amount for other segment items by reportable segment and a description of its composition. In addition, the amendment requires that a public entity provide all annual disclosures about a reportable segment’s profit or loss and assets currently required in interim periods and require that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2023-07 on its consolidated financial statements and related disclosures. This amendment will go into effect for the fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements To Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures. The amendments in this Update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information.

 

14

 

 

本更新中的修订要求实体每年(1)披露费用和(2)提供附加信息以对账目进行调和,这些账目达到定量门槛(如果这些调和账目的影响等于或超过按适用法定所得税率乘以税前收入(或损失)计算的金额的5%)。此外,要求上市公司提供有关费用和的某些定性披露。

 

本次更新中的修正要求所有实体每年披露支付的所得税金额(扣除已收回的退款), 按(1)联邦(国家)、州和外国税及(2)支付的所得税(扣除已收回的退款)等于或大于总所得税(扣除已收回的退款)5%的各个司法管辖区进行细分。

 

此更新还包括一些其他修改,以提高所得税披露的有效性,例如要求所有实体披露以下信息:

 

  1. 持续经营的收入 (或损失)在所得税费用(或收益)之前,分为国内和国外。
     
  2. 持续经营的所得税费用(或收益)按联邦(国家)、州和国外分列。

 

这项ASU中的修订要求对实体在采纳修订的年度报告期初的留存收益的期初余额(或其他适当的资本和净资产的元件)进行累积影响调整。允许提前采纳。公司目前正在评估ASU 2023-09对其合并基本报表和相关披露的影响。本修订将于2024年12月15日之后开始的年度期间生效。

 

首次公开发行业务收购与处置

 

欧盟 子公司购买协议

 

2024年5月,公司与一组个人达成协议,出售其全部拥有的子公司Shavita b.V.的股权和ARI物流b.V.的几乎所有资产。100% 截至这些财务报表发布时,交易尚未完成,因为还有待转移给公司的待付款义务以及尚未履行的购买者的其他货币义务。公司打算积极追究Shavita和购买者团体的权利。公司认为由ARI和Shavita交易产生的任何情况都不会对公司、其财务状况或经营业绩产生重大不利影响。 公司打算积极追究Shavita和购买者团体的权利。公司认为由ARI和Shavita交易产生的任何情况都不会对公司、其财务状况或经营业绩产生重大不利影响。

 

注意事项 4.金融工具的公允价值

 

在重复基础上计量的资产和负债

 

某些财务工具的账面金额,包括现金、应收账款、应付账款、某些应计费用和其他资产以及负债,由于这些工具的短期性质,其近似公允价值。

 

截至2023年12月31日,我们有需定期按公允价值计量的或有对价。

 

我们持有的金融工具按公允价值计量并在重复出现的基础上进行以下日期指示:

 

(以千为单位)     第1级   第2级   第3级   总计 
   汇总的合并财务报表
资产负债表说明
  年末公正价值为
2023年12月31日
 
(以千为单位)     第1级   第2级   第3级   总计 
负债:                       
未来对价 - 当前  应计费用和其他流动负债  $   $    1,500    1,500 
总负债     $   $   $1,500   $1,500 

 

在过去三个月和九个月内,在公允价值层次结构的一级和二级之间没有转移,在一级和二级之间也没有与一级之间的转移。 9月30日,分别是2024年和2023年。

 

15

 

 

Contingent Consideration

 

Each period we revalue our contingent consideration obligations associated with business acquisitions to their fair value. We estimate the fair value of the Product Launch Contingent Payments using a form of the scenario-based method, which includes significant unobservable inputs such as management’s identification of probability-weighted outcomes and a risk-adjusted discount rate over the earn-out period. Significant increases or decreases in these inputs could result in a significantly lower or higher fair value measurement of the contingent consideration liability. Changes in the fair value of contingent consideration are included within “Other income (expense), net” in our condensed consolidated statements of operations and comprehensive loss.

 

A reconciliation of our liabilities that are measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) is as follows:

 

(in thousands)  Nine Months Ended
September 30, 2024
 
Balance at December 31, 2023  $1,000 
Cash payments for earned contingent consideration    
Transfer to notes payable    
Gain from fair value adjustments included in results of operations   (1,000)
Balance September 30, 2024  $ 

 

(in thousands)  Nine Months Ended
September 30, 2023
 
Balance at December 31, 2022  $2,738 
Cash payments for earned contingent consideration   (350)
Transfer to notes payable   (1,150)
Loss (gain) from fair value adjustments included in results of operations   262 
Balance at September 30, 2023  $1,500 

 

Equity Securities Without a Readily Determinable Fair Value

 

Our investment in equity securities without readily determinable fair value consist of ownership interests in Airgraft Inc., Sun Grown Packaging, LLC (“Sun Grown”) and Vapor Dosing Technologies, Inc. (“VIVA”). We determined that our ownership interests do not provide us with significant influence over the operations of these investments. Accordingly, we account for our investments in these entities as equity securities.

 

16

 

 

Airgraft Inc., Sun Grown, and VIVA are private entities and their equity securities do not have a readily determinable fair value. We elected to measure these securities under the measurement alternative election at cost minus impairment, if any, with adjustments through earnings for observable price changes in orderly transactions for the identical or similar investment of the same issuer. We acquired our investments in Sun Grown and VIVA as part of our merger with KushCo, which we completed in August 2021. We did not identify any fair value adjustments related to these equity securities during the three and nine months ended September 30, 2024 and 2023, respectively.

 

As of September 30, 2024 and December 31, 2023, the carrying value of our investment in equity securities without a readily determinable fair value was approximately $1.9 million, respectively, included within “Other assets” in our condensed consolidated balance sheets.

 

NOTE 5. LEASES

 

Greenlane as a Lessee

 

As of September 30, 2024, we had facilities financed under operating leases consisting of warehouses and offices with lease term expirations between 2023 and 2027. Lease terms are generally three to seven years for warehouses and office space. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.

 

The following table provides details of our future minimum lease payments under operating lease liabilities recorded in our condensed consolidated balance sheet as of September 30, 2024. The table below does not include commitments that are contingent on events or other factors that are currently uncertain or unknown.

 

 

(in thousands)  Operating Leases 
Remainder of 2024  $230 
2025   942 
2026   81 
2027    
2028 and thereafter    
Total minimum lease payments  $1,253 
Less: imputed interest   41 
Present value of minimum lease payments  $1,212 
Less: current portion   886 
Long-term portion  $326 

 

Rent expense under operating leases was approximately $0.3 million and $0.8 million for the three and nine months ended September 30, 2024, respectively, and approximately $0.4 million and $1.5 million for the three and nine months ended September 30, 2023, respectively.

 

The following expenses related to our operating leases were included in “general and administrative” expenses within our condensed consolidated statements of operations and comprehensive loss:

 

(in thousands)  2024   2023 
   For the nine months ended September 30, 
(in thousands)  2024   2023 
Operating lease cost   685    1,474 
Variable lease cost       461 
Total lease cost  $685   $1,935 

 

The table below presents lease-related terms and discount rates as of September 30, 2024:

 

    Operating Leases  
Weighted average remaining lease terms     1.3 years  
Weighted average discount rate     2.3 %

 

17

 

 

NOTE 6. DEBT

 

Our debt balance, excluding operating lease liabilities and finance lease liabilities, consisted of the following amounts at the dates indicated:

 

(in thousands)  September 30, 2024   December 31, 2023 
   As of 
(in thousands)  September 30, 2024   December 31, 2023 
Future Receivables Financing  $4,617   $2,174 
Note payable   1,353     
Secured Bridge Loan   2,656    5,109 
Total long term debt   8,626    7,283 
Less unamortized debt issuance costs        
Less current portion of debt   (8,626)   (7,283)
Debt, net, excluding operating and finance leases and liabilities  $   $ 

 

Future Receivables Financings

 

In July, August, October, and November 2023, the Company received an aggregate of approximately $3.9 million in cash pursuant to the terms of future receivables financings (collectively, the “Future Receivables Financings”) entered into with two private lenders. The Company will make weekly payments under the Future Receivables Financings and is scheduled to repay the amounts due under the Future Receivables Financings in full in approximately six to eight months. The total amount to be repaid under the initial Future Receivables Financings was approximately $4.5 million. In connection with the Future Receivables Financings, the Company granted the lenders security interests in Company’s accounts receivable equal to the amounts due thereunder, and in connection with any event of default, the lenders may file financing statements evidencing the security interests. During the nine months ended September 30, 2024, the Company’s financings were in a series of transactions refinanced as they were not able to make the proscribed monthly payments for the repayment of cash advances. As such the refinancings restructured the payment schedule and the total balance increased to $4.6 million which included deferred financing fees of approximately $2.8 million.

 

Note Payable

 

On June 7, 2024, the Company entered into a subscription agreement for a note payable with Cobra Alternative Capital Strategies, LLC. As of September 30, 2024, the Company had been loaned $3.1 million with net cash proceeds of $2.6 million, with an remaining balance due of $1.0 million. The note was issued with a 20% original issue discount and is due in full on December 7, 2024. Upon default, the note can be converted at a variable price equal to 30% discount to the average daily volume weighted average price (“VWAP”) for the 20 trading days preceding the date of conversion. As of September 30, 2024, the note is not considered convertible.

 

Secured Bridge Loan

 

On September 22, 2023, the Company entered into a secured loan pursuant to a Loan and Security Agreement (the “September 2023 Loan Agreement”), dated as of September 22, 2023 with Synergy Imports, LLC (the “Secured Bridge Loan Lender” or “Synergy”).

 

Pursuant to the September 2023 Loan Agreement, the Secured Bridge Loan Lender agreed to make available to the Company a six-month bridge loan of $2.2 million in new funds. Additionally, the Secured Bridge Loan Lender agreed to defer payments totaling $2,028,604 already owed by the Company under existing payment obligations and potentially defer up to an additional $2,655,778 which may become due pursuant to existing agreements during the term of the September 2023 Loan Agreement.

 

Subject to certain exceptions, the Company agreed to pledge all of its assets, with the exception of deposit accounts and accounts receivable, as collateral. Additionally, the Company agreed to transfer one US patent and two related foreign patents and a related trademark in exchange for an exclusive license back of such assets in the area of smoking products and accessories in connection with the September 2023 Loan Agreement.

 

On May 6, 2024, the Company, Warehouse Goods and Synergy entered into an asset purchase agreement, dated May 1, 2024 (the “Asset Purchase Agreement”) pursuant to which Synergy purchased all of the intellectual property, a specified amount of inventory, and other assets related to the Eyce and DaVinci brands. In consideration for the acquisition, all parties entered into a loan modification agreement, effective May 1, 2024 (the “Loan Modification Agreement”) and an amended and restated secured promissory note, effective May 1, 2024 (the “Amended and Restated Secured Promissory Note”), an amendment to the original Eyce and Davinci Asset Purchase Agreements, a distribution agreement, the termination of a license granted by Eyce, and the termination of certain consulting and employment agreements. As part of the overall modification, the principal balance with Synergy decreased by $2.7 million from $5.1 million. Synergy acquired certain assets from the Company in exchange for the reduction in overall principal owed and as part of the transaction, the Company recognized a gain on the debt modification of $2.2 million. This amount is included in the accompanying financial statements within the statement of operations for the three and nine months ended September 30, 2024 within other income (expense). At September 30, 2024, $2.5 million of such financing remained outstanding. The updated date of maturity will be through the end of 2024. 

 

Future Minimum Principal Payments

 

The following table summarizes future scheduled minimum principal payments of debt at September 30, 2024. Future debt principal payments are presented based upon the stated maturity dates in the respective debt agreement.

 

(in thousands)  Remainder 2024   2025   2026   2027   2028   Total 
   Year Ending December 31, 
(in thousands)  Remainder 2024   2025   2026   2027   2028   Total 
Future Receivables Financing  $4,617   $   $   $   $   $4,617 
Note payable   1,353                    1,353 
Secured Bridge Loan   2,656                    2,656 
Total  $8,626   $   $   $   $   $8,626 

 

18

 

 

NOTE 7. COMMITMENTS AND CONTINGENCIES

 

Legal Proceedings

 

In the ordinary course of business, we are involved in various legal proceedings involving a variety of matters. We do not believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. We have not taken any reserves for litigation for the nine months ended September 30, 2024 and 2023, respectively.

 

Other Contingencies

 

We are potentially subject to claims related to various non-income taxes (such as sales, value added, consumption, and similar taxes) from various tax authorities, including in jurisdictions in which we already collect and remit such taxes. If the relevant taxing authorities were successfully to pursue these claims, we could be subject to significant additional tax liabilities.

 

See “Note 5—Leases” for details of our future minimum lease payments under operating lease liabilities. See “Note 11—Incomes Taxes” for information regarding income tax contingencies.

 

NOTE 8. SUPPLEMENTAL FINANCIAL STATEMENT INFORMATION

 

ERC Sale

 

As of December 31, 2022, we had recorded an Employee Retention Credit (“ERC”) receivable of $4.9 million within “Other current assets” on our consolidated balance sheets, and a corresponding amount was included in “Other income (expense), net” in our consolidated statement of operations and comprehensive loss for the year ended December 31, 2022. On February 16, 2023, two of Greenlane Holdings, Inc.’s subsidiaries, Warehouse Goods LLC and KIM International LLC (collectively, the “Company”), entered into an agreement with a third-party institutional investor pursuant to which the investor purchased, for approximately $4.9 million in cash, an economic participation interest, at a discount, in all of the Company’s rights to payment from the United States Internal Revenue Service with respect to the employee retention credits filed by the Company under the ERC program.

 

Other Current Assets

 

The following table summarizes the composition of other current assets as of the dates indicated:

 

(in thousands)  September 30, 2024   December 31, 2023 
   As of 
(in thousands)  September 30, 2024   December 31, 2023 
Other current assets:          
VAT refund receivable (Note 2)  $224   $78 
Prepaid expenses   109    1,207 
Indemnification receivable, net   7    7 
Customs bonds   1,122    1,229 
Other   817    798 
Other current assets  $2,279   $3,319 

 

19

 

 

Accrued Expenses and Other Current Liabilities

 

The following table summarizes the composition of accrued expenses and other current liabilities as of the dates indicated:

 

(in thousands)  September 30, 2024   December 31, 2023 
   As of 
(in thousands)  September 30, 2024   December 31, 2023 
Accrued expenses and other current liabilities:          
VAT payable (including amounts related to VAT matter described in Note 2)  $629   $313 
Contingent consideration       1,000 
Accrued employee compensation   1,122    861 
Accrued professional fees and other expenses   267    499 
Refund liability (including accounts receivable credit balances)       68 
Sales tax payable   507    315 
Accrued expenses and other current liabilities  $2,525   $3,056 

 

Customer Deposits

 

For certain product offerings we may receive a deposit from the customer (generally 25% - 50% of the total order cost, but the amount can vary by customer contract), when an order is placed by a customer. We typically complete orders related to customer deposits within one to six months from the date of order, depending on the complexity of the customization and the size of the order, but the order completion timeline can vary by product type and terms of sale with each customer. Changes in our customer deposits liability balance during the nine months ended September 30, 2024 were as follows:

 

(in thousands)  Customer Deposits 
Balance as of December 31, 2023  $2,775 
Increases due to deposits received, net of other adjustments    
Customer Overpayments    
Revenue recognized   (1,520)
Balance as of September 30, 2024  $1,255 

 

Accumulated Other Comprehensive Income

 

The components of accumulated other comprehensive income for the periods presented were as follows:

 

(in thousands)  Foreign Currency Translation   Unrealized Gain or (Loss) on Derivative Instrument   Total 
Balance at December 31, 2023  $      245   $         $245 
Other comprehensive income   3        3 
                
Balance at September 30, 2024  $248   $   $248 

 

(in thousands)  Foreign Currency Translation   Unrealized Gain or (Loss) on Derivative Instrument   Total 
Balance at December 31, 2022  $              55   $          $55 
Other comprehensive income (loss)   183        183 
Less: Other comprehensive (income) loss attributable to non-controlling interest            
Balance at September 30, 2023  $238   $   $238 

 

Supplier Concentration

 

Our four largest vendors accounted for an aggregate of approximately 43.8% and 18.2% of our total purchases for the three and nine months ended September 30, 2024, respectively, and an aggregate of approximately 89.9% and 82.2% of our total purchases for the three and nine months ended September 30, 2023, respectively.

 

20

 

 

Related Party Transactions

 

Nicholas Kovacevich, our former Chief Corporate Development Officer owns capital stock of Blum Holdings Inc. (“Blum”). Net sales to Blum totaled approximately $0.4 million for the year ended December 31, 2022. Total accounts receivable due from Blum were approximately $0.4 million as of September 30, 2024 and December 31, 2023, respectively. On February 8, 2023, we filed a lawsuit against Blum in Superior Court of California, Orange County, seeking to compel the repayment of Blum’s open balance due to us. As of the date of these financial statements were available to be issued, there has been a judgement received in favor of the Company.

 

Three individuals who were employees of the Company at the time are principals in Synergy Imports, LLC the Lender on the Secured Bridge Loan taken out on September 22, 2023, however, none were executive officers or directors of the Company

 

NOTE 9. STOCKHOLDERS’ EQUITY

 

Shares of our Class A common stock have both voting interests and economic interests (i.e., the right to receive distributions or dividends, whether cash or stock, and proceeds upon dissolution, winding up or liquidation), while shares of our Class B common stock have voting interests but no economic interests. Each share of our Class A common stock, and except as otherwise required in the A&R Charter, the holders of Common Stock will vote together as a single class on all matters (or, if any holders of our preferred stock are entitled to vote together with the holders of Common Stock, as a single class with such holders of preferred stock).

 

Effective June 5, 2023, we completed a one-for-10 reverse stock split (the “2023 Reverse Stock Split” and together with the 2022 Reverse Stock Split, the “Reverse Stock Splits”) of our issued and outstanding shares of Common Stock, as further described in “Note 2 - Summary of Significant Accounting Policies.” As a result of the 2023 Reverse Stock Split, every 10 shares of Common Stock issued and outstanding were converted into one share of Common Stock. We paid cash in lieu of fractional shares, and accordingly, no fractional shares were issued in connection with the 2023 Reverse Stock Split.

 

On June 18, 2024, the Board unanimously approved and declared advisable, and recommended that our stockholders approve at a Special Meeting that took place on July 29, 2024, the adoption of the 2024 Amendment to effect a reverse stock split of our Common Stock at any whole number between, and inclusive of, one-for-two to one-for-twenty. Approval of the Proposed 2024 Reverse Stock Split at the 2024 Special Meeting granted the Board the authority, but not the obligation, to file the 2024 Amendment to effect the Proposed 2024 Reverse Stock Split no later than August 5, 2024, with the exact ratio and timing of the Proposed 2024 Reverse Stock Split to be determined at the discretion of the Board. On July 23, 2024, the Board approved the reverse split at a ratio of one-for-11 and the Amendment has been filed with the Secretary of State of the State of Delaware, that became effective on August 5, 2024 at 12:01 AM Eastern Time, before the opening of trading on the Nasdaq. For additional information about the July 29, 2024 Special Meeting and the 2024 Reverse Stock Split, see the Company’s Definitive Proxy Statement filed with the SEC on June 28, 2024 and Form 8-K filed with the SEC on July 31, 2024.

 

The Reverse Stock Splits did not change the par value of the Common Stock or the authorized number of shares of Common Stock. All share and per share amounts in these unaudited condensed consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Splits, including reclassifying an amount equal to the reduction in par value of Common Stock to additional paid-in capital.

 

Non-Controlling Interest

 

As discussed in “Note 1—Business Operations and Organization”, we consolidate the financial results of the Operating Company in our consolidated financial statements and report a non-controlling interest related to the Common Units held by non-controlling interest holders. As of December 31, 2022, all Common Units of the Operating Company and Class B common stock had been exchanged for Class A common stock, and we owned 100.0% of the economic interests in the Operating Company. The non-controlling interest in the accompanying consolidated statements of operations and comprehensive loss represents the portion of the net loss attributable to the economic interest in the Operating Company previously held by the non-controlling holders of Common Units calculated based on the weighted average non-controlling interests’ ownership during the periods presented.

 

At-the-Market Equity Offering

 

In August 2021, we established an “at-the-market” equity offering program (the “ATM Program”) that provides for the sale of shares of our Class A common stock having an aggregate offering price of up to $50 million, from time to time, through Cowen and Company, LLC (“Cowen”), as the sales agent. Net proceeds from sales of our shares of Class A common stock under the ATM Program are expected to be used for working capital and general corporate purposes.

 

Sales of our Class A common stock under the ATM Program may be made by means of transactions that are deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act, including sales made directly on the Nasdaq Capital Market or sales made to or through a market maker or through an electronic communications network. We are under no obligation to offer and sell shares of our Class A common stock under the ATM Program.

 

21

 

 

Shares of our Class A common stock will be issued pursuant to our effective shelf registration statement on Form S-3 (File No. 333-257654), and a prospectus supplement relating to the Class A common stock that was filed with the Securities and Exchange Commission on April 18, 2022. Pursuant to Instruction I.B.6, in no event will the Company sell Class A common stock through the ATM Program with a value exceeding more than one-third of the Company’s “public float” (the market value of the Company’s Class A common stock and any other equity securities that it issues in the future that are held by non-affiliates) in any twelve-month period so long as the Company’s public float remains below $75.0 million.

 

On April 18, 2022, we entered into Amendment No. 1 (the “ATM Amendment”) to the sales agreement dated August 2, 2022 with Cowen. The purpose of the Amendment was to add the limitations imposed on the ATM Program by Instruction I.B.6 to the sales agreement. At the time of our entry into the ATM Amendment, approximately $37.3 million in shares remained available for issuance under the ATM Program.

 

Due to the untimely filing of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 we are unable to issue additional shares of Class A common stock pursuant to the ATM Program or otherwise use the Shelf Registration Statement for a period of 12 months, which will limit our liquidity options in the capital markets.

 

The table below summarizes sales of our Class A common stock under the ATM program:

 

($ in thousands)  August 2021 (Inception) through
September 30, 2024
 
Class A shares sold   8,842 
Gross proceeds  $12,684 
Fees paid to sales agent  $381 
Net proceeds  $12,303 

 

Common Stock and Warrant Offerings

 

July 2023 Offering

 

On June 29, 2023, we entered into securities purchase agreements with certain investors, pursuant to which we agreed to issue and sell an aggregate of 50,952 shares of our Class A common stock, pre-funded warrants to purchase up to 317,013 shares of our Class A common stock (the “July 2023 Pre-Funded Warrants”) and warrants to purchase up to 735,931 shares of our Class A common stock (the “July 2023 Standard Warrants”). The July 2023 units each consisted of one share of Class A common stock or a July 2023 Pre-Funded Warrant and two July 2023 Standard Warrants to purchase one share of our Class A common stock. The July 2023 units were offered pursuant to an effective Registration Statement on Form S-1. The July 2023 Standard Warrants are exercisable immediately at an exercise price equal to $1.05 per share of Class A common stock for a period of five years. Each July 2023 Pre-Funded Warrant is exercisable immediately with no expiration date for one share of Class A common stock at an exercise price of $0.0001. The July 2023 Offering generated gross proceeds of approximately $4.3 million and net proceeds to the Company of approximately $3.8 million.

 

As of the date of this Quarterly Report on Form 10-Q, all July 2023 Pre-Funded Warrants have been exercised, based upon which we issued additional shares of our Class A common stock, for de minimis net proceeds.

 

In connection with the July 2023 Offering, the Company entered into privately negotiated agreements with holders participating in the offering to amend existing outstanding warrants to purchase up to 122,215 shares of Class A common stock that were previously issued in connection with the June 2022 and October 2022 Offerings at exercise prices per share of $50.00 and $9.00, respectively, and expire on December 29, 2027 and November 1, 2029, respectively (collectively, the “Prior Warrants”), effective upon the closing of the July 2023 Offering to reduce the exercise price of the Prior Warrants to $1.05, the exercise price of the warrants to purchase shares of Class A common stock offered in the July 2023 Offering. All other terms of the Prior Warrants remained unchanged.

 

August 2024 Private Placement

 

On August 12, 2024, the Company entered into a securities purchase agreement with a single institutional investor pursuant to which we agreed to issue and sell an aggregate of 58,000 shares of our Class A common stock, pre-funded warrants to purchase up to 2,305,637 shares of our Class A common stock (the “August 2024 Pre-Funded Warrants”) and warrants to purchase up to 4,727,274 shares of our Class A common stock (the “August 2024 Standard Warrants”). for aggregate gross cash proceeds of $6.5 million. In connection with the private placement, the Company will issue an aggregate of 2,363,637 units and pre-funded units. The pre-funded units will be sold at the same purchase price as the units, less the pre-funded warrant exercise price of $0.00001. Each unit and pre-funded unit will consist of one share of common stock (or one pre-funded warrant) and two common warrants, each exercisable for one share of common stock at an exercise price of $2.50 per share. The common warrant will be exercisable on the initial exercise date described in the common warrant and will expire 5.0 years from such date.

 

As of September 30, 2024, there were 2,176,647 warrants that remained unexercised.

 

Net Loss Per Share

 

Basic net loss per share of Class A common stock is computed by dividing net loss attributable to Greenlane by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted net loss per share of Class A common stock is computed by dividing net loss attributable to Greenlane by the weighted-average number of shares of Class A common stock outstanding adjusted to give effect to potentially dilutive instruments.

 

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of our Class A common stock is as follows (in thousands, except per share amounts):

 

                 
   Three months ended September 30,   Nine months ended September 30, 
(in thousands, except per share data)  2024   2023   2024   2023 
                 
Numerator:                    
Net loss  $(3,757)  $(10,098)  $(8,882)  $(27,869)
Less: Net income (loss) attributable to non-controlling interests       19    (17)   (27)
Plus: Deemed Dividend on “October 2022 Standard Warrants”       (388)       (388)
Net loss attributable to Class A common stockholders  $(3,757)  $(10,467)  $(8,899)  $(28,284)
Denominator:                    
Weighted average shares of Class A common stock outstanding   1,647    501    726    265 
Net loss per share of Class A common stock - basic and diluted  $(2.28)  $(20.89)  $(12.26)  $(106.73)

 

22

 

 

As of September 30, 2024, there were 2,245,629 warrants that remained unexercised which we used in determining the weighted average shares outstanding.

 

For the three and nine months ended September 30, 2024 and 2023, respectively, stock options and warrants to purchase Class A common stock were excluded from the weighted-average in the computation of diluted net loss per share of Class A common stock because the effect would have been anti-dilutive.

 

NOTE 10. COMPENSATION PLANS

 

Amended and Restated 2019 Equity Incentive Plan

 

In April 2019, we adopted the 2019 Equity Incentive Plan (the “2019 Plan”). In August 2021, we adopted, and our shareholders approved, the Amended and Restated 2019 Equity Incentive Plan (the “Amended 2019 Plan”), which amends and restates the 2019 Plan in its entirety. At our 2022 Annual Meeting of Stockholders on August 4, 2022, stockholders approved the Second Amended and Restated 2019 Equity Incentive Plan (the “Second Amended 2019 Plan”) which, among other things, increased the number of shares of Class A common stock authorized for issuance under the Amended 2019 Plan. Following the effect of the Reverse Stock Splits, the total number of shares of Class A common stock authorized for issuance is 10,000 shares.

 

The Second Amended 2019 Plan provides eligible participants with compensation opportunities in the form of cash and equity incentive awards. The Second Amended 2019 Plan is designed to enhance our ability to attract, retain and motivate our employees, directors, and executive officers, and incentivizes them to increase our long-term growth and equity value in alignment with the interests of our stockholders.

 

On June 2, 2023, the Company’s stockholders approved a third amendment and restatement of the 2019 Plan (the “Third Amended Plan”). The Third Amended Plan, among other things, increases the number of shares of Class A common stock authorized for issuance under the Second Amended 2019 Plan by 19,078 shares to an aggregate of 29,078 shares. As of the date of this Quarterly Report on Form 10-Q, we have not filed a Registration Statement on Form S-8 with the Securities and Exchange Commission to register the additional shares authorized under the Third Amended Plan.

 

Equity-Based Compensation Expense

 

Equity-based compensation expense is included within “salaries, benefits and payroll taxes” in our condensed consolidated statements of operations and comprehensive loss. We recognized equity-based compensation expense as follows:

 

(in thousands)  2024   2023   2024   2023 
   For the three months ended
September 30,
   For the nine months ended
September 30,
 
(in thousands)  2024   2023   2024   2023 
Stock options - Class A common stock  $   $(77)  $   $2 
Restricted shares - Class A common stock       8    86    29 
Total equity-based compensation expense  $   $(69)  $86   $31 

 

As of September 30, 2024, there was no remaining unrecognized compensation expense.

 

23

 

 

NOTE 11. INCOME TAXES

 

As a result of the IPO and the related transactions completed in April 2019, we owned a portion of the Common Units of the Operating Company, which is treated as a partnership for U.S. federal and most applicable state and local income tax purposes. As a partnership, the Operating Company was generally not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by the Operating Company was passed through to and included in the taxable income or loss of its members, including Greenlane, on a pro-rata basis, in accordance with the terms of the Operating Agreement. The Operating Company was also subject to taxes in foreign jurisdictions. We are a corporation subject to U.S. federal income taxes, in addition to state and local income taxes, based on our share of the Operating Company’s pass-through taxable income.

 

Effective on December 31, 2022, the Operating Company became wholly owned by us. As a result, the Operating Company’s tax status was converted from a partnership to a disregarded entity. Starting in 2023, 100% of the Operating Company’s U.S. income and expenses is included in our US and state tax returns.

 

During the three and nine months ended September 30, 2024 and 2023, respectively, management performed an assessment of the realizability of our deferred tax assets based upon which management determined that it is not more likely than not that the results of operations will generate sufficient taxable income to realize portions of the net operating loss benefits. Consequently, we established a full valuation allowance against our deferred tax assets and reflected a carrying balance of $0 as of September 30, 2024 and December 31, 2023, respectively. In the event that management determines that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, an adjustment to the valuation allowance will be made, which would reduce December the provision for income taxes.

 

Uncertain Tax Positions

 

For the three and nine months ended September 30, 2024 and 2023, respectively, we did not have any unrecognized tax benefits as a result of tax positions taken during a prior period or during the current period. No interest or penalties have been recorded as a result of tax uncertainties. The Company is subject to audit examination for federal and state purposes for the years 2019 – 2023. As of the date these financial statements were issued, there were not any ongoing income tax audits.

 

Tax Receivable Agreement (TRA)

 

We entered into the TRA with the Operating Company and each of the members (other than Greenlane Holdings, Inc.) that provides for the payment by the Operating Company to the members of 85% of the amount of tax benefits, if any, that we may actually realize (or in some circumstances are deemed to realize) as a result of (i) increases in tax basis resulting from any future redemptions of Common Units as described in “Note 1—Business Operations and Organization” and (ii) certain other tax benefits attributable to payments made under the TRA.

 

The annual tax benefits are computed by calculating the income taxes due, including such tax benefits, and the income taxes due without such benefits. The Operating Company expects to benefit from the remaining 15% of any tax benefits that it may actually realize. The TRA payments are not conditioned upon any continued ownership interest in the Operating Company. The rights of each noncontrolling interest holder under the TRA are assignable to transferees of its interest in the Operating Company. The timing and amount of aggregate payments due under the TRA may vary based on a number of factors, including the amount and timing of the taxable income the Operating Company generates each year and the applicable tax rate.

 

As noted above, we evaluated the realizability of the deferred tax assets resulting from the IPO and the related transactions completed in April 2019 and established a full valuation allowance against those benefits. As a result, we determined that the amount or timing of payments to noncontrolling interest holders under the TRA are no longer probable or reasonably estimable. Based on this assessment, our TRA liability was $0 as of September 30, 2024 and December 31, 2023.

 

If utilization of the deferred tax assets subject to the TRA becomes more likely than not in the future, we will record a liability related to the TRA, which would be recognized as expense within our condensed consolidated statements of operations and comprehensive (loss) income.

 

During the three and nine months ended September 30, 2024 and 2023, respectively, we did not make any payments, inclusive of interest, to members of the Operating Company pursuant to the TRA.

 

24

 

 

NOTE 12. SUBSEQUENT EVENTS

 

On October 29, 2024, the Company entered into an Exchange Agreement with its Senior Subordinated Lender, whereby the Company agreed to exchange an aggregate of $4,617,307 of debt originally owed to Agile Capital Funding LLC and Cedar Advance LLC in a 3(a)(9) exchange for new Senior Subordinated Notes in the principal amount of $4,000,000 due one year from issuance (the “Exchange Note”), reducing outstanding indebtedness by approximately $617,000. The Exchange Note is convertible at the option of the holder at $3.17 per share. In connection with the Exchange, the Company issued an aggregate of 1,261,830 five year warrants with an exercise price of $3.04 per share (the “Exchange Warrants”).

 

In addition, pursuant to the terms of the Exchange Agreement, the Company agreed to issue warrants to the Holders, with an initial exercise price of $3.04, exercisable 180 days after issuance (the “Exchange Inducement Warrants”). The Exchange Inducement Warrants were issued to incentivize the holders to exercise some or all of their existing warrants originally issued on August 13, 2024 (the “Existing Warrants”) for cash, which existing warrants have an exercise price of $2.50 per share. The Exchange Inducement Warrants are initially exercisable for zero shares, but to the extent that the Holders exercise any of such Existing Warrants during the one-hundred sixty day inducement period, the Exchange Inducement Warrants will become exercisable on April 30, 2025 for 200% of the number of Existing Warrants exercised for cash during such inducement period.

 

Also, pursuant to the Exchange Agreement, the Senior Subordinated Lender agreed that it will exercise its Existing Warrants for cash prior to exercising any of its outstanding pre-funded warrants, contingent on the market price of the common stock being above $2.50 per share and certain other conditions. The above agreement will terminate upon the Company receiving certain cash proceeds and prepaying at least $2,250,000 of Cobra Alternative Capital Strategies LLC (“Cobra”) Notes.

 

On October 29, 2024, the Company entered into the First Amendment to Amended and Restated Secured Promissory Note (the “Note Amendment”) with Cobra. Pursuant to the Note Amendment, Cobra agreed to extend the Maturity Date of its senior promissory note dated May 1, 2024, which is currently due. The new Maturity Date will be October 29, 2025. In consideration for the extension, the Company (i) agreed to make such Notes convertible at the option of Cobra with a conversion price of $3.17 per share, (ii) agreed to prepay Cobra’s debt with 50% of any money raised by the Company from warrant exercise proceeds and from capital raise transactions, and (iii) issued Cobra an aggregate of 500,000 five year warrants with an exercise price of $3.04 per share which are identical to the Exchange Warrants.

 

25

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and related notes of Greenlane Holdings, Inc. and its consolidated subsidiaries (“Greenlane” and, collectively with the Operating Company and its consolidated subsidiaries, the “Company”, “we”, “us” and “our”) for the quarterly period ended September 30, 2024 included in Part I, Item 1 of this Quarterly Report on Form 10-Q, and the audited consolidated financial statements and related notes of Greenlane Holdings, Inc. for the year ended December 31, 2023, which are included in our Annual Report on Form 10-K.

 

Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q (“Form 10-Q”) contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Many of the forward-looking statements are located in Part I, Item 2 of this Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could” and similar expressions. Examples of forward-looking statements include, without limitation:

 

  statements regarding our growth and other strategies, results of operations or liquidity;
  statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance;
  statements regarding our industry;
  statements of management’s goals and objectives;
  statements regarding laws, regulations, and policies relevant to our business;
  projections of revenue, earnings, capital structure and other financial items;
  assumptions underlying statements regarding us or our business; and
  other similar expressions concerning matters that are not historical facts.

 

Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that might cause such a difference include those discussed in our filings with the SEC, under the heading “Risk Factors” in our Annual Report on Form 10-KA for the fiscal year ended December 31, 2023 (the “2023 Annual Report”) and in other documents that we file from time to time with the Securities and Exchange Commission (the “SEC”).

 

Forward-looking statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances, or achievements expressed or implied by the forward-looking statements. These risks include, but are not limited to, those listed below and those discussed in greater detail in Part I, Item 1A of the 2023 Annual Report under the heading “Risk Factors.”

 

  the potential delisting of our Class A common stock from Nasdaq;
  our expectations about our ability to fully execute actions and steps that would be probable of mitigating the existence of substantial doubt regarding our ability to continue as a going concern;
  our strategy, outlook and growth prospects;
  general economic trends and trends in the industry and markets in which we operate;
  our dependence on, and our ability to establish and maintain business relationships with, third-party suppliers and service suppliers;
  our ability to access capital;
  the competitive environment in which we operate;
  our vulnerability to third-party transportation risks;
  the impact of governmental laws and regulations and the outcomes of regulatory or agency proceedings;
  our ability to accurately estimate demand for our products and maintain appropriate levels of inventory;
  our ability to maintain or improve our operating margins and meet sales expectations;
  our ability to adapt to changes in consumer spending and general economic conditions, including the current inflationary environment;
  our ability to use or license certain trademarks;
  our ability to maintain consumer brand recognition and loyalty of our products;
  our and our customers’ ability to establish or maintain banking relationships;
  fluctuations in U.S. federal, state, local and foreign tax obligation and changes in tariffs;
  our ability to address product defects;
  our exposure to potential various claims, lawsuits and administrative proceedings;
  contamination of, or damage to, our products;

 

26

 

 

  any unfavorable scientific studies on the long-term health risks of vaporizers, electronic cigarettes, or cannabis or hemp-derived products, including CBD;
  failure of our information technology systems to support our current and growing business;
  our ability to prevent and recover from internet security breaches;
  our ability to generate adequate cash from our existing business to support our growth;
  our ability to raise capital on favorable terms, or at all, to support the continued growth of the business;
  our ability to protect our intellectual property rights;
  our dependence on continued market acceptance of our products by consumers;
  our sensitivity to global economic conditions and international trade issues;
  our ability to comply with certain environmental, health and safety regulations;
  our ability to successfully identify and complete strategic acquisitions;
  natural disasters, adverse weather conditions, operating hazards, environmental incidents and labor disputes;
  increased costs as a result of being a public company; and
  our failure to maintain adequate internal controls over financial reporting.

 

Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

 

The forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Consequently, you should not place undue reliance on forward-looking statements.

 

Overview

 

Founded in 2005, Greenlane is the premier global platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. In 2021, we completed several acquisitions along with a transformative merger with KushCo Holdings, adding a significant industrial line of business to the Greenlane platform. These acquisitions strengthened our leading position as a consumer ancillary products business and significantly expanded our customer network, bringing strategic relationships with leading cannabis multi-state-operators (“MSOs”), cannabis single-state operators (“SSOs”), and Canadian licensed-producers (“LPs”). Greenlane is a leading ancillary cannabis company, providing a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (“related Cannabis Operators”), in addition to specialty retailers, smoke shops and head shops, convenience stores, and consumers directly through our own proprietary web stores and large online marketplaces such as Amazon.

 

We have been developing a world-class portfolio of our own proprietary brands (the “Greenlane Brands”) and carefully curated third-party products that we believe will, over time, deliver higher margins and create long-term value for our customers and shareholders. Our wholly-owned Greenlane Brands includes our recently launched more affordable product line – Groove, innovative silicone pipes and accessories and premium ancillary product brand – Higher Standards. We also have category exclusive licenses for the premium Marley Natural branded products, as well as the K. Haring Glass Collection.

 

Since the end of 2021, the Company has invested significantly in technology, including its e-commerce platforms, internal ERP systems, and B2B capabilities. Our world-class product portfolio is offered to customers through our proprietary, owned and operated e-commerce platforms which include Vapor.com, PuffItUp.com, HigherStandards.com, MarleyNaturalShop.com and Wholesale.Greenlane.com. These platforms allow us to reach customers directly with helpful resources and a seamless purchasing experience.

 

We merchandise vaporizers, packaging, and other ancillary products in the United States, Canada, Europe and Latin America. We distribute products to retailers through wholesale operations and distribute products to consumers through our e-commerce platforms We operate our own distribution centers in the United States, while also utilizing third-party logistics (“3PL”) locations in Canada. We have made tremendous progress consolidating and streamlining our warehouse and distribution operations over the last two years.

 

We manage our business in two different, but complementary, business segments. The first is the Consumer Goods segment, which focuses on serving consumers across wholesale, retail, and e-commerce operations—offering both our Greenlane Brands as well as ancillary products and accessories from select leading third-party brands, such as Storz and Bickel, Grenco Science, PAX, Arizer and more. The Consumer Goods segment forms a central part of our growth strategy, especially as it relates to scaling our own portfolio of higher-margin proprietary owned brands. In addition to our Consumer Goods segment, we have our Industrial Goods segment, which focuses on serving Cannabis Operators by providing ancillary products essential to their daily operations and growth, such as packaging and vaporization solutions, including our Greenlane Brand Pollen Gear. Refer to “Note 12— Segment Reporting” within this Form 10-Q for additional information on our reportable segments.

 

27

 

 

Plan to Accelerate Path to Profitability and Capitalize the Business

 

In today’s economic landscape, particularly within the cannabis industry, achieving profitability and preserving working capital are paramount. At Greenlane, we are intensely focused on making our business profitable and well-capitalized for long-term sustainability. Our key initiatives include:

 

  1. Technology Enhancements: We remain fully committed to improving our technology, particularly our B2B and e-commerce platforms, to provide a seamless shopping experience for our wholesale and retail customers.
     
  2. Facility Footprint Rationalization: In 2023 and 2024, we optimized our facilities footprint by reducing warehouse and office space while increasing operational efficiency and improving fulfillment practices. The full benefit of those efforts are expected to be realized in 2024.
     
  3. Headcount Reduction: We have significantly reduced our headcount and associated salary expenses, focusing on maintaining a core group of key employees as we collectively right-size the business.
     
  4. Cost Structure Optimization: We continue to reduce our overall cost structure while improving margins. In April 2023, we formed two strategic partnerships (described below in greater detail) to increase margins and significantly reduce working capital requirements in our Industrial Goods segment. Similarly, our Consumer Goods segment restructured arrangements with several third-party brands in 2022 and 2023 to reduce our working capital needs.
     
  5. Inventory Management: In 2023, we implemented a new inventory management and lifecycle strategy that is focused on a quarterly turn and a regular review of inventory to avoid future write-offs.
     
  6. Sales Force Upgrade: We have upgraded and will continue to upgrade our sales force from a solely account management centric team to a skilled and driven sales team to acquire new customers while maintaining excellent service with our existing customers
     
  7. Product Innovation: We launched Groove, an innovative new product line with a value-based price point and in 2024 we have begun to expand our product offering to further enhance our assortment available to our customers.
     
  8. Capital Investment: We continue to seek opportunities for securing investment capital to leverage our platform, increase availability and reduce stockouts of our high demand third-party brands, invest in marketing and sales, and improve our product offerings.

 

Management believes that these initiatives will significantly reduce costs, help accelerate the Company’s path to profitability, support business growth, and allow the Company to reinvest capital into its highest demand and highest potential product lines.

 

During 2023 and 2024, the Company received capital from various sources permitting it to right-size the business and position the company for growth. Such sources are described in greater detail in the Liquidity and Capital Resources Section of this report.

 

During 2023 and 2024, the Company also entered into certain arrangements to reduce working capital requirements and improve its balance sheet.

 

In April 2023, we entered into two strategic partnerships. First, we entered into a strategic partnership (the “MJ Packaging Partnership”) with A&A Global Imports d/b/a MarijuanaPackaging.com (“MJ Pack”), a leading provider of packaging solutions to the cannabis industry. On August 8, 2024 the Company terminated its strategic partnership with MJ Packaging and is resuming its business as a direct provider of packaging solutions to the cannabis industry.  MJ Packaging however, remains a distribution customer of the Company. Second, we entered into a strategic partnership with an affiliate of one of our existing vape suppliers (“Vape Partner”) to service certain key customers with vaporizer goods and services (the “Vape Partnership”). As part of the Vape Partnership, we will introduce our Vape Partner to certain key customers, assist with the promotion and the sale of certain vaporizer goods and services, and help coordinate the logistics, storage and distribution of such vaporizer products. If our Vape Partner and key customer(s) enter into a direct relationship, the customers would directly purchase vaporizer goods and services, which we currently sell them, directly from our Vape Partner and we would no longer need to purchase such vape inventory on behalf of such key customer(s). In exchange we would earn quarterly and annual commission payments from our strategic partner. While the strategic partnership may result in a decrease in top line revenue for these vape products, this partnership combined with some of our other restructuring initiatives should allow us to reduce our overall cost-structure and enhance our margins, thereby improving our balance sheet.

 

28

 

 

On May 6, 2024, the Company, Warehouse Goods and Synergy entered into an asset purchase agreement, dated May 1, 2024 (the “Asset Purchase Agreement”) pursuant to which Synergy purchased all of the intellectual property, a specified amount of inventory, and other assets related to the Eyce and DaVinci brands. In consideration for the acquisition, all parties entered into a loan modification agreement, effective May 1, 2024 (the “Loan Modification Agreement”) and an amended and restated secured promissory note, effective May 1, 2024 (the “Amended and Restated Secured Promissory Note”), an amendment to the original Eyce and Davinci Asset Purchase Agreements, a distribution agreement, the termination of a license granted by Eyce, and the termination of certain consulting and employment agreements. As part of the overall modification, the principal balance with Synergy decreased by $2.7 million from $5.1 million. Synergy acquired certain assets from the Company in exchange for the reduction in overall principal owed and as part of the transaction, the Company recognized a gain on the debt modification of $2.2 million. This amount is included in the accompanying financial statements within the statement of operations for the three and nine months ended September 30, 2024 within other income (expense). At September 30, 2024, $2.7 million of such financing remained outstanding. As of the filing date of this statement and as a result of restructuring efforts, the maturity of this note is October 2025.

 

USPS PACT Act Exemption

 

On January 11, 2022, we announced via press release that the United States Postal Service (the “USPS”) had approved our application for a business and regulatory exemption to the PACT Act (with respect to the business and regulatory exemption granted by the USPS, the “PACT Act Exemption”), allowing us to ship vaporizers and accessories classified as electronic nicotine delivery systems (“ENDS”) products to other compliant businesses. With this approval, over 97% of our total annual sales became eligible for shipment by freight, USPS and other major parcel carriers. The PACT Act Exemption also enables us to partner with other businesses that ship ENDS products and had their supply chains disrupted by PACT Act compliance.

 

On June 24, 2022, we provided via press release an update on the progress of the PACT Act Exemption, following our successful implementation of the controls, processes and systems required by the USPS in connection with the shipment of ENDS products. We expect the ability to fulfill ENDS orders with the USPS to allow us to reduce shipping costs, decrease fulfillment times and enhance the overall customer experience for approved wholesale customers.

 

Reverse Stock Split

 

On June 2, 2023, we filed a Certificate of Amendment to the A&R Charter with the SSSD, which effected a one-for-10 reverse stock split (the “2023 Reverse Stock Split” and together with the 2022 Reverse Stock Split, the “Reverse Stock Splits”) of our issued and outstanding shares of Common Stock at 5:01 PM Eastern Time on June 5, 2023. As a result of the 2023 Reverse Stock Split, every 10 shares of common stock issued and outstanding were converted into one share of common stock. We paid cash in lieu of fractional shares, and accordingly, no fractional shares were issued in connection with the 2023 Reverse Stock Split.

 

The Reverse Stock Split did not change the par value of the Common Stock or the authorized number of shares of Common Stock. All outstanding options, restricted stock awards, warrants and other securities entitling their holders to purchase or otherwise receive shares of our Common Stock have been adjusted as a result of the Reverse Stock Split, as required by the terms of each security. The number of shares available to be awarded under our Second Amended and Restated 2019 Equity Incentive Plan have also been appropriately adjusted. See “Note 10 — Compensation Plans” for more information.

 

On July 23, 2024, the Board approved the reverse split at a ratio of one-for-11 and the Amendment has been filed with the Secretary of State of the State of Delaware, which became effective on August 5, 2024 at 12:01 AM Eastern Time, before the opening of trading on the Nasdaq.

 

All share and per share amounts were retroactively adjusted for all periods presented to give effect to the Reverse Stock Split.

 

Critical Accounting Estimates

 

We prepare our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. We evaluate our estimates and assumptions on an ongoing basis. We base our estimates on historical experience, outside advice from parties believed to be experts in such matters, and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Judgments and uncertainties affecting the application of those policies may result in materially different amounts being reported under different conditions or using different assumptions. See “Note 2—Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Form 10-K for a description the significant accounting policies and methods used in the preparation of our consolidated financial statements.

 

Inventories

 

Inventories, consisting of finished products, are primarily accounted for using the weighted-average method, and are valued at the lower of cost and net realizable value. This valuation requires us to make judgments, based on currently available information, about the likely method of disposition, such as through sales to customers or liquidations. Assumptions about the future disposition of inventory are inherently uncertain and changes in our estimates and assumptions may cause us to realize material write-downs in the future.

 

29

 

 

Income Taxes and TRA Liability

 

We are a corporation subject to income taxes in the United States. Certain subsidiaries of the Operating Company are taxable separately from us. Our proportional share of the Operating Company’s subsidiaries’ provisions are included in our consolidated financial statements.

 

As of December 31, 2022, we held all the outstanding Common Units in the Operating Company and are the sole member. As a result, in 2023, 100% of the Operating Company’s US and state income and expenses are now included in our US and state tax returns.

 

Our deferred income tax assets and liabilities are computed for differences between the tax basis and financial statement amounts that will result in taxable or deductible amounts in the future. We compute deferred balances based on enacted tax laws and applicable rates for the periods in which the differences are expected to affect taxable income. A valuation allowance is recognized for deferred tax assets if it is more likely than not that some portion or all of the net deferred tax assets will not be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If we determine we would be able to realize our deferred tax assets for which a valuation allowance had been recorded, then we would adjust the deferred tax asset valuation allowance, which would reduce our provision for income taxes.

 

We evaluate the tax positions taken on income tax returns that remain open and positions expected to be taken on the current year tax returns to identify uncertain tax positions. Unrecognized tax benefits on uncertain tax positions are recorded on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the largest amount of tax benefit that is more than 50 percent likely to be realized is recognized. Interest and penalties related to unrecognized tax benefits are recorded in income tax benefit. We have no uncertain tax positions that qualify for inclusion in our consolidated financial statements.

 

In addition to tax expenses, we may incur expenses related to our operations and may be required to make payments under the Tax Receivable Agreement (the “TRA”), which could be significant. Pursuant to the Greenlane Operating Agreement, Greenlane Holdings, LLC will generally make pro rata tax distributions to its members in an amount sufficient to fund all or part of their tax obligations with respect to the taxable income of Greenlane Holdings, LLC that is allocated to them and possibly in excess of such amount.

 

Recent Accounting Pronouncements

 

See “Note 2—Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of our Form 10-K filed on July 19, 2024.

 

Results of Operations

 

The following table presents operating results for the three and nine months ended September 30, 2024 and 2023:

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
           % of Net sales   Change           % of Net sales   Change 
   2024   2023   2024   2023   $   %   2024   2023   2024   2023   $   % 
                                                 
Net sales   4,038    11,800    100.0%   100.0%  $(7,762)   (65.8)%   11,616    55,384    100.0%   100.0%  $(43,768)   (79.0)%
Cost of sales   1,011    8,671    25.0%   73.5%   (7,660)   (88.3)%   6,066    42,162    52.2%   76.1%   (36,096)   (85.6)%
Gross profit   3,027    3,129    75.0%   26.5%   (102)   (3.3)%   5,550    13,222    47.8%   23.9%   (7,672)   (58.0)%
                                                             
Operating expenses:                                                            
Salaries, benefits and payroll taxes   1,609    4,059    39.8%   34.4%   (2,450)   (60.4)%   6,066    14,586    52.2%   26.3%   (8,520)   (58.4)%
General and administrative   1,771    5,433    43.9%   46.0%   (3,662)   (67.4)%   6,864    20,209    59.1%   36.5%   (13,345)   (66.0)%
Depreciation and amortization   185    524    4.6%   7.4%   (339)   (64.7)%   635    1,492    5.5%   2.7%   (857)   (57.4)%
Total operating expenses   3,565    10,016    88.3%   84.8%   (6,451)   (64.4)%   13,565    36,287    116.8%   65.5%   (22,722)   (62.6)%
Loss from operations   (538)   (6,887)   (13.3)%   (58.3)%   6,349    (92.2)%   (8,015)   (23,065)   (69.0)%   (41.6)%   15,050    (65.3)%
                                                             
Other income (expense), net:                                                            
Interest expense   (3,219)   (3,415)   (79.7)%   (28.9)%   196    (5.7)%   (4,030)   (5,148)   (34.7)%   (9.3)%   1,118    (21.7)%
Change in fair value of contingent consideration   -    -    -    -    -    -%   1,000    -    8.6%   -    1,000    100.0%
Gain on extinguishment of debt   -    -    -    -    -    -%   2,166    -    18.6%   -    2,166    100.0%
Other income (expense), net   -    204    -    1.7%   (204)   (100)%   (3)   338    -%   0.6%   (341)   (100.9)%
Total other expense, net   (3,219)   (3,211)   (79.7)%   (27.2)%   (8)   0.2%   (867)   (4,810)   (7.5)%   (8.7)   3,943    (82.0)
Loss before income taxes   (3,757)   (10,098)   (93.0)%   (85.5)%   6,341    (62.8)%   (8,882)   (27,875)   (76.5)%   (50.3)%   18,993    (68.1)%
Provision for (benefit from) income taxes   -    -    -%   %   -    -%   -    (6)   -%   %   6    (100.0)%
Net loss   (3,757)   (10,098)   (93.0)%   (85.5)%   6,341    (62.8)%   (8,882)   (27,869)   (76.5)%   (50.3)%   18,987    (68.1)%
Net income (loss) attributable to non-controlling interest   -    19    -    0.2%   (19)   (100.0)%   (17)   (27)   (0.1)%   (0.2)%   10    (37.0)%
Net loss attributable to Greenlane Holdings, Inc.  $(3,757)  $(10,117)   (93.0)%   (85.7)%  $6,360    (62.9)%  $(8,865)  $(27,842)   (76.4)%   (50.1)%   18,977    (68.2)%

 

30

 

 

Consolidated Results of Operations

 

Net Sales

 

For the three months ended September 30, 2024, net sales were approximately $4.0 million, compared to approximately $11.8 million for the same period in 2024, representing a decrease of $7.8 million, or 65.8%. The year-over-year decrease in net sales was due to a major restructuring of our Industrial Group in April of 2023, involving our packaging and industrial vaping product lines; transitioning much of this business from a gross sales to a commission structure to preserve working capital. Revenues decreased in the Consumer Brands Group due, in part, to restructuring efforts and shift in strategy to focus on in-house brands that carry a higher margin profile while rationalizing third-party brand offerings, which generated top line revenue with lower margins. The consumer products were affected by the inability to access capital markets on equitable terms, resulting in stock-outs and shortages of higher velocity inventory. The Company is continuing to focus on profitable revenue and as a result top line revenue has significantly been reduced. Concurrently, the Company has continued its focus on right-sizing the business during the fiscal year ended December 31, 2023 and through present, in an effort to reduce sales and marketing costs and reduce or eliminate certain administrative functions.

 

For the nine months ended September 30, 2024, net sales were approximately $11.6 million, compared to approximately $55.4 million for the same period in 2024, representing a decrease of $43.8 million, or 79.0%. The year-over-year decrease in net sales was due to a major restructuring of our Industrial Group in April of 2023, involving our packaging and industrial vaping product lines; transitioning much of this business from a gross sales to a commission structure to preserve working capital. Revenues decreased in the Consumer Brands Group due, in part, to restructuring efforts and shift in strategy to focus on in-house brands that carry a higher margin profile while rationalizing third-party brand offerings, which generated top line revenue with lower margins. The consumer products were affected by the inability to access capital markets on equitable terms, resulting in stock-outs and shortages of higher velocity inventory. The Company is continuing to focus on profitable revenue and as a result top line revenue has significantly been reduced. Concurrently, the Company has continued its focus on right-sizing the business during the fiscal year ended December 31, 2023 and through present, in an effort to reduce sales and marketing costs and reduce or eliminate certain administrative functions.

 

Cost of Sales and Gross Margin

 

For the three months ended September 30, 2024, cost of sales decreased by $7.7 million, or 88.3%, as compared to the same period in 2023. The decrease in the cost of sales is driven by the 65.8% decrease in revenue in addition to a decrease in damaged and obsolete inventory write-offs.

 

For the nine months ended September 30, 2024, cost of sales decreased by $36.1 million, or 85.6%, as compared to the same period in 2023. The decrease in the cost of sales is driven by the 79.0% decrease in revenue in addition to a decrease in damaged and obsolete inventory write-offs.

 

Gross margin percentage increased 48.4% to 75.0% for the three months ended September 30, 2024, compared to 26.5% for the same period in 2023.

 

Gross margin percentage increased 23.9% to 47.8% for the nine months ended September 30, 2024, compared to 23.9% for the same period in 2023.

 

Salaries, Benefits and Payroll Taxes

 

Salaries, benefits and payroll taxes expenses decreased by approximately $2.5 million, or 60.4%, to $1.6 million for the three months ended September 30, 2024, compared to $4.1 million for the same period in 2023. The decrease is related to the reduction in workforce to right-size the business and focus on profitability.

 

Salaries, benefits and payroll taxes expenses decreased by approximately $8.5 million, or 58.4%, to $6.1 million for the nine months ended September 30, 2024, compared to $14.6 million for the same period in 2023. The decrease is related to the reduction in workforce to right-size the business and focus on profitability.

 

As we continue to closely monitor the evolving business landscape, we remain focused on identifying cost-saving opportunities while delivering on our strategy to recruit, train, promote and retain the most talented and success-driven personnel in the industry.

 

31

 

 

General and Administrative Expenses

 

General and administrative expenses decreased by approximately $3.7 million, or 67.4%, for the three months ended September 30, 2024, compared to the same period in 2023. The decrease is related to major restructuring effort by the Company to reduce cost and right-size the business. Compared with the first quarter of 2023, the Company focused on reduction across the board in general and administrative expenses and saw large decreases in professional and outside services, facility expenses, outbound freight, other general and administrative, marketing, taxes and licenses, and general insurance.

 

General and administrative expenses decreased by approximately $13.3 million, or 66.0%, for the nine months ended September 30, 2024, compared to the same period in 2023. The decrease is related to major restructuring effort by the Company to reduce cost and right-size the business. Compared with the first quarter of 2023, the Company focused on reduction across the board in general and administrative expenses and saw large decreases in professional and outside services, facility expenses, outbound freight, other general and administrative, marketing, taxes and licenses, and general insurance.

 

Depreciation and Amortization Expense

 

Depreciation and amortization expense decreased $0.3 million, or 64.7%, for the three months ended September 30, 2024, compared to the same period in 2023. The decrease is related to a major restructuring effort to reduce cost and right-size the business resulting in the sale and disposal of assets related to reducing our warehousing and office footprint.

 

Depreciation and amortization expense decreased $0.9 million, or 57.4%, for the nine months ended September 30, 2024, compared to the same period in 2023. The decrease is related to a major restructuring effort to reduce cost and right-size the business resulting in the sale and disposal of assets related to reducing our warehousing and office footprint.

 

Other Income (Expense), Net

 

Interest expense.

 

Interest expense decreased approximately $0.2 million for the three months ended September 30, 2024 compared to the same period in 2023. The decrease is primarily related to reduction in overall debt financing and refinancing debt for more favorable terms.

 

Interest expense decreased approximately $1.1 million for the nine months ended September 30, 2024 compared to the same period in 2023. The decrease is primarily related to reduction in overall debt financing and refinancing debt for more favorable terms.

 

Change in fair value of contingent consideration

 

There was a change in fair value of contingent consideration of approximately $1.0 million for the nine months ended September 30, 2024 compared to the same period in 2023. The change is primarily related to known reductions in earnouts related to Davinci and Eyce products.

 

32

 

 

Gain on debt extinguishment

 

There was an increase in gain on debt extinguishment of approximately $2.2 million for the nine months ended September 30, 2024, compared to the same period in 2023. The change is primarily related to a difference in the reduction in overall debt modification with Synergy, offset by the carrying value of the Davinci and Eyce assets acquired by Synergy. For further information, see Note 6, “Debt” of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q.

 

Provision for (Benefit from) Income Taxes

 

For the three and nine months ended September 30, 2024 and 2023, respectively, the effective tax rate differed from the U.S. federal statutory tax rate of 21% primarily due to the Operating Company’s pass-through structure for U.S. income tax purposes (through December 31, 2022), the relative mix in earnings and losses in the U.S. versus foreign tax jurisdictions, and the valuation allowance against the deferred tax asset.

 

Liquidity, Capital Resources and Going Concern

 

Our primary requirements for liquidity and capital are working capital, debt service related to recent acquisitions and general corporate needs. Our primary sources of liquidity are our cash on hand and the cash flow that we generate from our operations, as well as proceeds other equity issuances. As of September 30, 2024, we had approximately $2.3 million of cash, of which none was restricted and $0.1 million was held in foreign bank accounts, and approximately $2.5 million of negative working capital, which is calculated as total current assets minus total current liabilities, as compared to approximately $0.5 million of cash, of which $0.1 million was held in foreign bank accounts, and approximately $3.7 million of working capital as of December 31, 2023. The repatriation of cash balances from our foreign subsidiaries could have adverse tax impacts or be subject to capital controls; however, these balances are generally available to fund the ordinary business operations of our foreign subsidiaries without legal or other restrictions.

 

We believe that our cash on hand and the cash flow that we generate from our operations will not be sufficient to fund our working capital and capital expenditure requirements, as well as our debt repayments and other liquidity requirements associated with our existing operations, for the next 12 months. Based on our cash on hand and working capital at September 30, 2024, we may have insufficient cash to fund planned operations into the fourth quarter of 2024. This is evident from our continued efforts to raise capital and leverage external funding to fulfil our capital needs as highlighted below.

 

33

 

 

ATM Program and Shelf Registration Statement

 

We formerly used a shelf registration statement on Form S-3 (the “Shelf Registration Statement”) to conduct securities offerings. In August 2021, we filed a prospectus supplement and established an “at-the-market” equity offering program (the “ATM Program”) that provided for the sale of shares of our Class A common stock having an aggregate offering price of up to $50 million, from time to time.

 

Since the launch of the ATM program in August 2021 and through December 31, 2022, we sold shares of our Class A common stock which generated gross proceeds of approximately $12.7 million and we paid fees to the sales agent of approximately $0.4 million. Due to the untimely filing of certain of our Quarterly and Annual Reports, we are unable to issue additional shares of Class A common stock pursuant to the ATM Program or otherwise use the Shelf Registration Statement.

 

Common Stock and Warrant Offerings

 

On June 29, 2023, we entered into securities purchase agreements with certain investors, pursuant to which we agreed to issue and sell an aggregate of 50,952 shares of our Class A common stock, pre-funded warrants to purchase up to 317,013 shares of our Class A Common Stock (the “July 2023 Pre-Funded Warrants”) and warrants to purchase up to 735,931 shares of our Class A common stock (the “July 2023 Standard Warrants”). The July 2023 units were offered pursuant to a Registration Statement on Form S-1 (the “July 2023 Offering”). The July 2023 Offering generated gross proceeds of approximately $4.3 million and net proceeds to the Company of approximately $3.8 million and closed on July 3, 2023.

 

On August 12, 2024, the Company entered into a securities purchase agreement with a single institutional investor for aggregate gross cash proceeds of $6.5 million. In connection with the private placement, the Company will issue an aggregate of 2,363,637 units and pre-funded units. The pre-funded units will be sold at the same purchase price as the units, less the pre-funded warrant exercise price of $0.00001. Each unit and pre-funded unit will consist of one share of common stock (or one pre-funded warrant) and two common warrants, each exercisable for one share of common stock at an exercise price of $2.50 per share. The common warrant will be exercisable on the initial exercise date described in the common warrant and will expire 5.0 years from such date.

 

Asset-Based Loan

 

On August 9, 2022, we entered into an asset-based loan agreement dated as of August 8, 2022 (the “Loan Agreement”), which made available to the Company a term loan of up to $15.0 million. On February 9, 2023, we entered into Amendment No. 2 to the Loan Agreement, in which we agreed to, among other things, voluntarily prepay approximately $6.6 million (inclusive of early termination fees and expenses) under the terms provided for under the Loan Agreement and the lenders under the Loan Agreement agreed to release $5.7 million in funds held in a blocked account pursuant to the terms of the Loan Agreement.

 

On August 7, 2023, we repaid the approximately $4.3 million in aggregate principal amount (the “Loan Repayment”) which remained outstanding under the terms of the Loan Agreement. As a result of the Loan Repayment, the Company has been released from its obligations under the Loan Agreement, in accordance with the terms of the Loan Agreement. See “Note 6 - Long Term Debt” for more information.

 

ERC Sale

 

On February 16, 2023, two of our wholly owned subsidiaries, Warehouse Goods LLC and KIM International LLC, entered into an agreement with a third-party institutional investor pursuant to which the investor purchased, for approximately $4.9 million in cash, an economic participation interest, at a discount, in our rights to payment from the United States Internal Revenue Service for certain periods with respect to the employee retention credits filed by us under the Employee Retention Credit program.

 

Future Receivables Financings

 

In July, August, October, and November 2023, the Company received an aggregate of approximately $3.9 million in cash pursuant to the terms of future receivables financings (collectively, the “Future Receivables Financings”) entered into with two private lenders. See “Note 6 - Long Term Debt” for more information.

 

Notes Payable

 

On June 7, 2024, the Company entered into a subscription agreement with Cobra Alternative Capital Strategies, LLC. As of September 30, 2024, the Company has been loaned $3.1 million with net cash proceeds of $2.6 million with a remaining balance of $1.0 million. The note was issued with a 20% original issue discount and is due in full on December 7, 2024. See “Note 6 - Long Term Debt” for more information.

 

34

 

 

Management Initiatives

 

We have completed several initiatives to optimize our working capital requirements. We launched Groove, a new, innovative Greenlane Brands product line, and we also rationalized our third-party brands product offering, which enables us to reduce inventory carrying costs and working capital requirements.

 

In April 2023, we entered into two strategic partnerships. First, we entered into a strategic partnership (the “MJ Packaging Partnership”) with A&A Global Imports d/b/a MarijuanaPackaging.com (“MJ Pack”), a provider of packaging solutions to the cannabis industry. On August 8, 2024 the Company terminated its strategic partnership with MJ Packaging and is resuming its business as a direct provider of packaging solutions to the cannabis industry.  MJ Packaging however, remains a distribution customer of the Company. Second, we entered into a strategic partnership with an affiliate of one of our existing vape suppliers (“Vape Partner”) to service certain key customers with vaporizer goods and services (the “Vape Partnership”). As part of the Vape Partnership, we will introduce our Vape Partner to certain key customers, assist with the promotion and the sale of certain vaporizer goods and services, and help coordinate the logistics, storage and distribution of such vaporizer products. If our Vape Partner and key customer(s) enter into a direct relationship, the customers would directly purchase vaporizer goods and services, which we currently sell them, directly from our Vape Partner and we would no longer need to purchase such vape inventory on behalf of such key customer(s). In exchange we would earn quarterly and annual commission payments from our strategic partners. While the strategic partnership may result in a decrease in top line revenue for these vape products, this partnership combined with some of our other restructuring initiatives should allow us to reduce our overall cost-structure and enhance our margins, thereby improving our balance sheet.

 

We have successfully renegotiated supplier partnership terms and are continuing to improve working capital arrangements with suppliers. We have made progress consolidating and streamlining our office, warehouse, and distribution operations footprint. We have reduced our workforce by approximately 49% throughout fiscal year 2023 to reduce costs and align with our revenue projections.

 

We have incurred net losses of $8.9 million and $27.8 million for the nine months ended September 30, 2024 and 2023, respectively. For the nine months ended September 30, 2024, cash used in operating activities was $5.2 million and cash used in operating activities for the year ended December 31, 2023 was $1.8 million. The recent macroeconomic environment has caused weaker demand than contemplated under our business plan, resulting in a reduction in projected revenue and cash flows for the twelve-month period included in the going concern evaluation.

 

As a result of our losses and our projected cash needs, combined with our current liquidity level, substantial doubt exists about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve the Company’s liquidity and profitability, which includes, without limitation:

 

  Further reducing operating costs expense by taking additional restructuring actions to align cost with revenue to achieve profitability.
     
  Increasing revenue by introducing new products and acquiring new customers.
     
  Execute on strategic partnerships accretive to margins and operating cash
     
  Seeking additional capital through the issuance of debt or equity securities.

 

Our opinions concerning liquidity are based on currently available information. To the extent this information proves to be inaccurate, or if circumstances change, future availability of trade credit or other sources of financing may be reduced and our liquidity could be adversely affected. Our future capital requirements and the adequacy of available funds will depend on many factors, including those described in the section titled “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023. Depending on the severity and direct impact of these factors on us, we may be unable to secure additional financing to meet our operating requirements on terms favorable to us, or at all.

 

As of September 30, 2024, we did not have any off-balance sheet arrangements that are reasonably likely to have a material current or future effect on our financial condition, results of operations, liquidity, capital expenditures, or capital resources.

 

35

 

 

Cash Flows

 

The following summary of cash flows for the periods indicated has been derived from our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q:

 

   Nine Months Ended
September 30,
 
(in thousands)  2024   2023 
Net cash (used in) provided by operating activities  $(5,232)  $4,656 
Net cash used in investing activities   (173)   (253)
Net cash provided by (used in) financing activities   7,248    (12,133)

 

Net Cash (Used in) Provided by Operating Activities

 

During the nine months ended September 30, 2024, net cash used in operating activities of $5.2 million consisted of a net loss of $8.8 million, offset partially by non-cash adjustments to the net loss of $1.0 million and a $1.2 million decrease in working capital driven by decreases in inventories of $4.2 million and decreases in accrued expenses of $0.5 million reduced by a decrease in customer deposits of $1.5 million and an increase in accounts receivable of $0.7 million.

 

During the nine months ended September 30, 2023, net cash “provided” by operating activities of approximately $1.2 million consisted of a net loss of $27.9 million offset by non-cash adjustments to net loss of approximately $4.4 million and a $24.7 million increase in working capital driven by an $18 million decrease in inventory, a $4.7 million decrease in accounts receivable, and a $4.0 million decrease in other assets reduced by a $3.1 million decrease in accounts payable.

 

Net Cash Used in Investing Activities

 

During the nine months ended September 30, 2024, net cash used in investing activities of approximately $0.2 million consisted primarily of capital expenditures.

 

During the nine months ended September 30, 2023, net cash provided by investing activities of approximately $0.6 million , offset by cash used for development costs for our new enterprise resource planning (ERP) system of $0.6 million.

 

Net Cash Provided bv (Used in) Financing Activities

 

During the nine months ended September 30, 2024, net cash provided by financing activities of approximately $7.2 million primarily consisted of approximately $0.9 million in payments on loans against future accounts receivable, approximately $0.2 million in proceeds from future receivables financing, approximately $2.1 million in proceeds from notes payable, $3.0 in repayments on notes payable, and $5.6 million in net proceeds from the issuance of common stock.

 

36

 

 

During the nine months ended September 30, 2023, net cash provided by financing activities of approximately $10.5 million primarily consisted of cash proceeds of approximately $3.9 million from the issuance of Class A common stock through our ATM Program and the June 2022 Offering, offset primarily by approximately $2.5 million in payments on notes payable, finance lease obligations and other long-term liabilities, and approximately $0.3 million in payments of contingent consideration related to the Eyce LLC acquisition.

 

Cybersecurity

 

Risk Management and Strategy

 

We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data.

 

Managing Material Risks & Integrated Overall Risk Management

 

We have strategically integrated cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management. This integration ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management team continuously evaluates and addresses cybersecurity risks in alignment with our business objectives and operational needs.

 

Oversee Third-party Risk

 

Because we are aware of the risks associated with third-party service providers, we have implemented stringent processes to oversee and manage these risks. We conduct thorough security assessments of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with our cybersecurity standards. The monitoring includes annual assessments of the SOC reports of our providers and implementing complementary controls. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third-parties.

 

Risks from Cybersecurity Threats

 

We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not required.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Evaluation of Disclosure Controls and Procedures

 

We have established disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow for timely decisions regarding disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

 

Under the supervision and with the participation of management, including our Chief Executive Officer and our Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2024. Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of September 30, 2024, our disclosure controls and procedures were not effective because of the material weaknesses in our internal control over financial reporting described in Item 9A of Part II of our Annual Report on Form 10-K for the year ended December 31, 2023, which have not yet been remediated as of September 30, 2024.

 

Material Weaknesses Remediation Plan and Status

 

As previously described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2021, we began implementing a remediation plan to address the material weaknesses identified in the prior year, and our management continues to be actively engaged in the remediation efforts.

 

As previously disclosed, in 2020, we began a multi-year implementation of a new ERP system, which will replace our existing core financial systems, and which was completed in 2023. Management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures, based upon which, management focused its allocation of organizational resources to ensure the successful implementation of the new ERP system during 2023, and is continuing to add additional processes for the design and implementation of effective control activities. Conversely, management noted limited efforts related to re-designing user access roles and permissions in the legacy ERP system. Based on these considerations, and subject to management’s ongoing assessment, we do not expect that the previously reported material weaknesses related to ineffective user access controls will be considered remediated until our new ERP system has been fully utilize to its potential and we have properly set controls in place. Additionally, to remediate the identified material weaknesses, we are continuing to take the following remediation actions:

 

  implement enhancements to company-wide risk assessment processes and to process and control documentation;
  enhance the Company’s review and sign-off procedures for IT implementations;
  implement additional review procedures designed to enhance the control owner’s execution of control activities, including entity level controls, through the implementation of improved documentation standards evidencing execution of these controls, oversight, and training;
  improve control activities and procedures associated with certain accounting areas, including proper segregation of duties and assigning personnel with the appropriate experience as preparers and reviewers over analyses relating to such accounting areas;
  educate and train control owners regarding internal control processes to mitigate identified risks and maintain adequate documentation to evidence the effective design and operation of such processes;
  and implement enhanced controls to monitor the effectiveness of the underlying business process controls that are dependent on the data and financial reports generated from the relevant information systems.

 

37

 

 

We are also continuing to evaluate additional controls and procedures that may be required to remediate the identified material weaknesses. We cannot provide assurances that the previously reported material weaknesses will be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

 

Changes in Internal Control Over Financial Reporting

 

As discussed above, in 2020 we began a multi-year implementation of a new ERP system which fully replaced our legacy financial systems in 2023. The ERP system is designed to accurately maintain the Company’s financial records, enhance the flow of financial information, improve data management and provide timely information to our management team. Subsequent to implementation of the new ERP system, we are continuing to change certain processes and procedures which, in turn, are expected to result in changes to our internal control over financial reporting. As such changes occur, we will evaluate quarterly whether such changes materially affect our internal control over financial reporting.

 

There were no other changes to our internal control over financial reporting that occurred during the quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

For a description of our material pending legal proceedings, see Note 7 of the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on July 19, 2024, except as set forth below.

 

There is substantial doubt about our ability to continue as a going concern through the next 12 months from the date of the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

 

The Company has incurred net losses of $8.9 million and $27.8 million for the nine months ended September 30, 2024 and the prior year comparable period, respectively. For the nine months ended September 30, 2024, cash used in operating activities was $5.2 million, and cash used in operating activities for the year ended December 31, 2023 was $1.8 million. Based on our cash on hand and working capital at September 30, 2024, we may have insufficient cash to fund planned operations into the fourth quarter of 2024. As a result of our losses and our projected cash needs, combined with our current liquidity level, substantial doubt exists about the Company’s ability to continue as a going concern over the next 12 months. The recent macroeconomic environment has caused weaker demand than contemplated under the Company’s business plan, resulting in a reduction in projected revenue and cash flows for the twelve-month period included in the going concern evaluation.

 

Our ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve months to improve the our liquidity and profitability, which includes, without limitation:

 

  Further reducing operating costs expense by taking additional restructuring actions to align cost with revenue
  Increasing revenue by introducing new products and acquiring new customers.
  Execute on strategic partnerships accretive to margins and operating cash
  Seeking additional capital through the issuance of equity securities or obtaining debt financing.

 

There can be no assurance that any such measures will be successful. If we are not successful in improving our liquidity position and the profitability of our operations, we may need to consider all strategic alternatives, including seeking additional debt or equity capital, reducing or delaying our business activities and strategic initiatives, or selling assets, other strategic transactions and/or other measures, including receivership or, to the extent available, bankruptcy protection. In addition, the perception that we may not be able to continue as a going concern may cause vendors and customers to choose not to do business with us due to concerns about our ability to meet our contractual obligations. If we seek additional financing to fund our operations and there remains substantial doubt about our ability to continue as a going concern, our financing sources may be unwilling to provide additional funding to us on commercially reasonable terms or at all. The consolidated financial statements do not include any adjustments that may result from the outcome of this going concern uncertainty. Such adjustments could be material.

 

38

 

 

We have failed, and may continue to fail, to meet the listing standards of Nasdaq, and as a result our Class A common stock may become delisted, which could have a material adverse effect on the liquidity of our Class A common stock.

 

If we fail to continue to satisfy the continued listing requirements of Nasdaq, such as the corporate governance or public float requirements, or the minimum closing bid price requirement, Nasdaq will take steps to de-list our Class A common stock. As a result of several factors, including but not limited to our financial performance, market sentiment about the cannabis industry, volatility in the financial markets generally due to the tightening of monetary policy by the Board of Governors of the United States Federal Reserve Bank (the “Federal Reserve”) and other geopolitical events, events such as the ongoing wars around the world, the per share price of our Class A common stock has declined below the minimum bid price threshold required for continued listing. Such a de-listing would likely have a negative effect on the price of our Class A common stock and would impair your ability to sell or purchase our Class A common stock when you wish to do so, as well as adversely affect our ability to issue additional securities and obtain additional financing in the future.

 

On August 21, 2023, we received a letter from the staff of Nasdaq indicating that we were not in compliance with Nasdaq Listing Rule 5450(a)(1) because the closing bid price per share for our Class A common stock had closed below $1.00 for the previous 30 consecutive business days (the “Minimum Bid Price Requirement”). We were given 180 days, or until February 20, 2024 to regain compliance with the Minimum Bid Price Requirement. We also filed an application to transfer the listing of our Class A common stock from the Nasdaq Global Market to the Nasdaq Capital Market, which transfer was approved and occurred on February 9, 2024. As a result of the transfer, we became eligible to request an additional an additional 180-day compliance period.

 

On February 21, 2024, Nasdaq notified us in writing that while we had not regained compliance with the Minimum Bid Price Requirement, we were eligible for an additional 180-day compliance period, or until August 19, 2024, to regain compliance with the Minimum Bid Price Requirement. Nasdaq’s determination was based on us having met the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on our written notice to Nasdaq of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

 

If we do not regain compliance during the second 180-day period, then Nasdaq will notify us of its determination to delist our Class A common stock, at which point we would have an opportunity to appeal the delisting determination to a hearings panel. We would remain listed on Nasdaq pending the hearings panel’s decision. There can be no assurance that, if we do appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful.

 

On January 24, 2024, Gina Collins gave notice of her resignation from our Board of Directors and from each committee of the Board, effective immediately. Ms. Collins was an independent director, and as a result of her resignation, we no longer comply with the majority independent board requirement of Nasdaq as set forth in Nasdaq Listing Rule 5605(b)(1) because independent directors do not comprise a majority of the Board of Directors, and Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rule 5605(c)(2)(A) because the Audit Committee of the Board of Directors is not comprised of at least three independent directors.

 

On January 29, 2024, in accordance with Nasdaq Listing Rules, we notified Nasdaq of Ms. Collins’ resignation and the resulting non-compliance. On January 30, 2024, we received a notice from Nasdaq acknowledging the fact that we do not meet the requirements of such rules. In accordance with Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4), to regain compliance with the Nasdaq Listing Rules, we have until the earlier of our next annual stockholders meeting or January 24, 2025.

 

On April 18, 2024, we received a notice from Nasdaq stating that because we had not yet filed our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, we were no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.

 

On May 21, 2024, we received a notice from Nasdaq stating that because we had not yet filed our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, we were no longer in compliance with Nasdaq Listing Rule 5250(c)(1).

 

The Company had 60 calendar days from April 18, 2024, or until June 17, 2024, to regain compliance by filing the Form 10-K and the Form 10-Q or to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. We timely submitted the plan to regain compliance to Nasdaq and Nasdaq granted us additional time to file the Form 10K and 10Q. As of the date of this filing we have filed both the 10K and 10Q within the additional time period granted.

 

39

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit Number   Description
4.1   Form of July 2023 Standard Warrant (Incorporated by reference to Exhibit 4.1 to Greenlane’s Current Report on Form 8-K, filed on July 3, 2023).
4.2   Form of July 2023 Pre-Funded Warrant (Incorporated by reference to Exhibit 4.2 to Greenlane’s Current Report on Form 8-K, filed on July 3, 2023).
4.3   Form of July 2023 Warrant Amendment (Incorporated by reference to Exhibit 4.3 to Greenlane’s Current Report on Form 8-K, filed on July 3, 2023).
10.1   Form of July 2023 Securities Purchase Agreement (Incorporated by reference to Exhibit 10.1 to Greenlane’s Current Report on Form 8-K, filed on July 3, 2023).
10.2   Placement Agency Agreement, dated as of June 29, 2023 (Incorporated by reference to Exhibit 10.2 to Greenlane’s Current Report on Form 8-K, filed on July 3, 2023).
10.3   Loan and Security Agreement, dated as of September 22, 2023, between Greenlane and Synergy Imports, LLC. (Incorporated by reference to Exhibit 10.3 to Greenlane’s Quarterly Report on Form 10-Q, filed on January 9, 2024).
10.4   Secured Promissory Note, dated as of September 22, 2023, between Greenlane and Synergy Imports, LLC. (Incorporated by reference to Exhibit 10.4 to Greenlane’s Quarterly Report on Form 10-Q, filed on January 9, 2024).
10.5   Asset Purchase Agreement, effective May 1, 2024, by and among Greenlane Holdings, Inc, Warehouse Goods LLC and Synergy Imports LLC (Incorporated by reference to Exhibit 10.1 to Greenlane’s Current Report on Form 8-K, filed on May 10, 2024).
10.6   Loan Modification Agreement, effective May 1, 2024, by and among Warehouse Goods LLC, Synergy Imports LLC and the Guarantors as defined therein (Incorporated by reference to Exhibit 10.2 to Greenlane’s Current Report on Form 8-K, filed on May 10, 2024).
10.7   Amended and Restated Secured Promissory Note, effective May 1, 2024, by Warehouse Goods LLC and Synergy Imports LLC (Incorporated by reference to Exhibit 10.3 to Greenlane’s Current Report on Form 8-K, filed on May 10, 2024).
10.8   Subscription Agreement, effective June 7, 2024, by Warehouse Goods LLC and Greenlane Holdings, Inc.
31.1*   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*   The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, were formatted in Inline XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations and Comprehensive Loss, (iii) Condensed Consolidated Statements of Stockholders’ Equity, and (iv) Condensed Consolidated Statements of Cash Flows. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104*   Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL.

 

* Filed herewith.

**Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.

 

40

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  GREENLANE HOLDINGS, INC.
     
Date: August 14, 2024 By: /s/ Barbara Sher
    Barbara Sher Chief Executive Officer
(Principal Executive Officer)
     
  GREENLANE HOLDINGS, INC.
     
Date: August 14, 2024 By: /s/ Lana Reeve
    Lana Reeve Chief Financial and Legal Officer
(Principal Financial and Accounting Officer)

 

41